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Chapter 1
General introduction
1

1.1. Neuroprotection by steroid hormones in aging and disease 3
With the considerable increase in life expectancy and a consequently older population,
there are increased demands in successful aging strategies that lower the probability of
disease and allow an active life with high cognitive and physical capacity. Dementing
diseases will soon become main causes of disability, without proper neuroprotective
treatments (Schumacher et al., 2003). The fact that levels of some steroid hormones
markedly decrease with age and the evident sex-specific differences in incidence and
course of many neurodegenerative disorders (Schulman, 2007) proposed the involvement
of sex hormones in neurodegeneration. The risk of Alzheimer’s and Parkinson’s Diseases
in post-menopausal women was reported to have a direct correlation with the estrogen
decline (Schumacher et al., 2003). Several studies have shown that estrogen replacement
therapy has successfully reduced the incidence of these diseases in post-menopausal
women as well as improved cognitive and memory tests (Schulman, 2007; Peri and Serio,
2008).
1.1 Neuroprotection by steroid hormones in aging and dis-
ease
Steroid hormones have become favorites for neuroprotection treatments on the one side
because of their vital importance on the functioning of the central nervous system (Behl,
2003), the regulation of neurotransmitter systems, the promotion of neuron viability and
myelinization and a positive influence in cognitive processes of learning and memory. On
the other side, unconjugated steroids easily cross the blood-brain-barrier and accumulate
throughout the brain. Additionally, neurosteroids are produced locally in the brain (Schu-
macher et al., 2003; Prange-Kiel et al., 2006; Von Schassen et al., 2006), and the stimulation
of this process is another therapeutic possibility. The increasing incidence of neurode-
generative diseases demands for further research in the field of neuroprotection and the
clarification of the cell global process. The cellular mechanisms of the steroid-mediated
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neuroprotection have been shown to involve direct interaction with neural cells and indi-
rect effects through other cells, from which astrocytes are the most probable intermediaries
(see chapter 1.3).
1.2 Steroid hormones in brain development
Steroid hormones are known to be important regulatory signals in biological functions and
for brain development (Hutchison et al., 1997; Beyer, 1999; Mendez et al., 2005; Daniel, 2006;
McCarthy, 2008). The developing and adult brain cells express receptors for progesterone
(PR) and estrogen (ER) (Zhang et al., 2002; Mitra et al., 2003; Quadros et al., 2007), being
therefore unmistakable targets of these hormones, even though during development, male
have a stable PR presence, while female has little. The PR is transcribed by activated ER,
showing that the effects caused by these hormones are intimately connected. Estrogen
plays an essential role in late embryonic and early postnatal brain development, controlling
cell growth, neurons and astrocytes morphometry and tissue differentiation, regulating
cell apoptotic degeneration, synaptogenesis, organization of brain circuits and also the
sex-specific differentiation of the CNS (Mesano and Jaffe, 1997; Beyer, 1999; Woo et al., 2001;
McCarthy, 2008). Interestingly, some of the most obvious sex differences are in neurological
and psychiatric disorders, women being more likely to suffer from depression, multiple
sclerosis and Alzheimer’s disease, and male youngsters showing more often signs of
attention-deficit hyperactivity, autism and dyslexia, while older men have more often
Parkinson’s disease (Schumacher et al., 2003; Schulman, 2007). As most brain sexual
differences are derived from differences in early steroid hormone exposure, it is possible
that sex differences in some disorders are partly influenced by abnormal steroid exposure
or action in brain development. Moreover, the tissue- or brain region-specificity of some
mutations could be connected to a time-point in development.
Estrogen does not only originate from the foetuses gonads and the feto-placenta-
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maternal unit (Tuchinsky et al., 1972; Trotter et al., 1999), but is also synthesized locally
in the nervous tissues. Aromatase P450, the enzyme responsible for the transformation
of testosterone in estrogen, is expressed in neurons of the developing and adult brain
(Schumacher et al., 2003; Prange-Kiel et al., 2006; Von Schassen et al., 2006). Estrogen can
also be synthesized de novo from cholesterol and the necessary enzymes are also present
in the female and male developing brain. Because of local synthesis, steroid hormones
can reach much higher local concentrations than anticipated and the greater aromatase
activity in males than in females might be responsible for the sex brain dimorphism
(Hutchison et al., 1997; Beyer, 1999; Quadros et al., 2007). Estrogen, estrogen’s receptors
and P450 aromatase are at their highest levels in the brain either prenatally or in the first
post-natal days, later abating to the adult base levels. This time interval is believed to be
the estrogen’s sensitivity-window which allows for major permanent brain modifications,
including brain sex differences connected to adult sexual behaviour (McCarthy, 2008).
Because of these substantial and permanent effects in brain morphology and function
potentially due to estrogen action, the developing brain has unique characteristics to guide
or restrict the effects of this hormone, ensuring proper establishment of functional features,
the early embryonic cell differentiation and modulation of motor and cognitive processes
(Mendez et al., 2005; Daniel, 2006; McCarthy 2008). The aromatase sub cellular localization
next to synaptic terminals shows a possible E action like a neurotransmitter. Estrogen
receptors were also found in the axon and dendrites terminals, seemingly too far to return
to the nucleus for transcription activation, suggesting a non-transcriptional effect of ER in
the nervous system, or most probably, a local interaction with neighbouring mitochondria
which locate next to synapses (McCarthy, 2008). To understand these diverse sex and
tissue-specific phenotypes, it is critical to elucidate the processes of steroid hormone action
and the possible interactions with mitochondria, in development and in connection to
abnormal cell conditions.
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1.3 Astrocyte mediation of steroid hormone neuroprotec-
tion
In the past years, the neuroprotective aspects of estrogen (E) and progesterone (P) in the
central nervous system (CNS) have been analysed using in vitro and in vivo approaches.
Besides direct interactions of E and P with neurons (Kipp et al., 2006; Stein et al., 2008), there
are indications of indirect protective effects. Estrogen’s neuroprotective characteristics
have repeatedly been demonstrated in vivo and in organotypical cultures (Dhapandani
and Brann, 2002; Simpkins et al., 2005), suggesting the involvement of a non-neuronal brain
cell type in the protective function. Of the non-neuronal brain cell types, astrocytes have
the greatest potential for a critical role in the mediation of steroid-related neuroprotective
effects. Astrocytes are the most abundant type of glial cells in the brain and are located
juxtaposition to neurons, outnumbering them by a 10:1 ratio in the cortex. Additionally,
ablation of astrocytes in vivo results in a significant decrease of neuronal survival (Cui et
al., 2001). Furthermore, astrocytes are well-described target cells for E and P, expressing
the related steroid receptors (Jung-Testas et al., 1992; Santagati et al., 1994; Beyer, 1999;
Quadros et al., 2007). As to the mechanisms involved in the indirect steroid-mediated
neuroprotection through astrocytes, recent research has uncovered several vital functions
which show that astrocytes, as well as other glial cells, are not mere structural support.
Astrocytes play vital roles on the CNS, such as energy metabolism and protection of
neurons, regulation of cerebral blood flow, coupling neuronal activity and regulation of
synapses. Astrocytes extend processes that contact the brain vasculature and envelop
synapses. They transport nutrients to neurons, supporting neuronal metabolism and
neurotransmitter synthesis. Astrocytes further maintain the extracellular environment,
regulating ion concentrations and acid-base balance and importing extracellular glutamate
(Azcoitia et al., 2001; Maragakis and Rothstein, 2006, Pellerin et al., 2007; Schousboe et al.,
2007). They are involved in the regulation of growth, cell proliferation, and neuroprotection
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in the brain (Beyer, 1999; Beyer et al., 2003; Garcia-Segura et al., 2003; Kajta and Beyer, 2003;
Kipp et al., 2006; McCarthy, 2008). Estrogen-induced changes of physiological parameters
occur either in a direct non-genomic fashion (Beyer and Raab, 1998), or indirectly via
interactions with nuclear and non-nuclear estrogen receptors (ER) that appear to be
essential for estrogen-dependent gene expression and activation of various intracellular
signalling pathways (Garcia-Segura, 2001; Kajta and Beyer, 2003; Beyer and Raab, 1998;
Collins and Webb, 1999; Behl, 2003; Beyer et al., 2003; Arnold and Beyer, 2009). Besides
the above described supportive and protective function, astrocytes role in the energy
homeostasis of the brain, point at astrocyte mitochondria as an interesting compartment
involved in neuroprotection.
1.4 Mitochondria
Mitochondria are particular cell organelles with specializations that point to their main
function, the production of energy required for cellular processes. They are unique in
having their own genetic material, called mitochondrial DNA (mtDNA) in multiple copies.
Mitochondria are essential for a wide range of vital cell functions as metabolism, cell
signaling, growth, cell proliferation and also apoptosis, thus playing an important role in
development, aging and many diseases.
1.4.1 Mitochondria in aging and disease
Mitochondria play a fundamental role in many essential cell functions, including energy
metabolism, thermogenesis, intracellular calcium homeostasis, cell growth, division, sig-
nalling and also regulation of apoptosis (Bettini and Maggi, 1992; Behl, 2002; Chen et al.,
2004). Mitochondrial dysfunction affects not only the biochemical pathways located in
mitochondria, but also the pathways located in the cytoplasm and can therefore cause
important imbalance due to diminished cell energy, production of reactive oxygen species,
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disturbance of ionic balance and cytochrome C release, lately leading to apoptosis (James
et al., 2003; Yoon et al., 2003; Lee et al., 2004; Chen et al., 2005).
Mitochondria have their own genetic encoding molecules, the mitochondrial DNA
(mtDNA) which is a 16.56 kbp circular double-stranded molecule, encoding 13 polypep-
tides, 12S and 16S rRNA and 22 transfer-RNAs, all essential for the proper functioning of
mitochondria, and interestingly, there are no non-coding sections of genetic material in
mtDNA. The 13 polypeptides encoded in mtDNA are all subunits of the respiratory chain
complexes I, III, IV and V, only complex II is exclusively encoded by the nuclear genome.
The compact structure of mtDNA, the lack of histone protection as well as the insufficient
reparation mechanisms, and the exposition to the ROS by-products of the respiration tak-
ing place in the organelle, make the mtDNA ten to twenty times more prone to mutations
than the nuclear DNA (ncDNA) (Zeviani and Donato, 2004). But due to heteroplasmy,
which is the simultaneous presence of mtDNA in multiple copies, possibly wild type and
mutated, and mitochondrial dynamics (see Chapter 1.4.5), mutations accumulate without
major symptoms until a threshold is reached (Nakada et al., 2001).
Mitochondrial essential functions and characteristics explain the direct connection
of their dysfunction to aging and various diseases including cancer, obesity, diabetes,
cardiovascular disorders and several neurodegenerative diseases such as amyotrophic
lateral sclerosis (ALS), autosomal dominant optic atrophy, stroke, Charcot-Marie-Tooth,
Parkinson’s, Huntington’s and Alzheimer’s diseases and others, stressing the importance
of understanding the mechanisms underlying mitochondrial functions (Alexander et al.,
2000; Delettre et al., 2000 Bach et al., 2003; Zuchner et al., 2004; Zeviani and Donato, 2004;
Chen et al., 2004; Kijima et al., 2005; Chen and Chan, 2005; Singh et al., 2006; Thomas
and Beal 2007; Poole et al., 2008; Schapira, 2008; Tatsuta and Langer, 2008). The new
field of ’mitochondrial diseases’ includes a heterogeneous group of clinical phenotypes
derived from a dysfunction of mitochondria and/or from abnormalities in mitochondrial
DNA. Defects of the respiratory chain and oxidative phosphorilation are the main cause of
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mitochondrial disorders (Schapira, 2008) but these can also derive from abnormalities in
metabolic pathways partially located in mitochondria. Furthermore, symptoms may be
manifested at any age and the disorder may affect any tissue isolated or in combination
with others, the tissues having higher energy demands, like muscles, brain, kidney and
endocrine organs being more prone to being affected (Weissig et al., 2004; Armstrong,
2007). Mitochondrial diseases have unique characteristics not only because mitochondrial
functions have vital importance for the cell function, but also due to the way they are often
inherited. The mtDNA is normally derived only from the mother’s oocyte, the father’s
sperm mtDNA usually not contributing to the fetus mtDNA. Depending whether the
genetic defect is located on the mtDNA of the mother or on the ncDNA of one of the parents,
so there is the respective inheritance pattern.The recent research on mitochondrial diseases,
led to the emergence of a whole new field of biomedical research, the ’mitochondrial
medicine’ focusing on mitochondrial-target therapeutics (Weissig et al., 2004; Armstrong,
2007) and stressing the importance of understanding mitochondrial mechanisms and their
regulation.
1.4.2 Interaction of steroid hormones with mitochondria
The cell functions managed by mitochondria are interestingly also modulated by steroid
hormones (Nilson et al., 2002; Kipp et al., 2006; Arnold and Beyer 2009). Estrogens have
repeatedly been reported to play an important role in the regulation of mitochondrial
function, such as energy metabolism, cell signalling, calcium homeostasis, and apoptosis
(Bettini and Maggi, 1992; Behl, 2002; Chen et al., 2004; Kipp et al., 2006). Because mito-
chondria function as integrators of diverse cellular stress and toxic signals (Greenamyre et
al., 1999; Reynolds, 1999; Choo et al., 2003; Beal, 2005), they seem to be perfect targets for
steroid hormone regulation. Although the mechanisms for these actions are still not fully
understood, it was found that mitochondria interact with glucocorticoid, estrogen, andro-
gen, and progesterone receptors (Chen et al., 2004; Yang et al., 2004; Gavrilova-Jordan,
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2007). Recent studies have shown that E promotes the expression of mitochondria-encoded
subunits of the respiratory chain, thereby influencing mitochondrial respiratory activity
and enhancing functional efficiency (Araujo et al., 2008; Irwin et al., 2008). Estrogen was
also shown to have direct interactions with the respiratory chain complexes (Zheng and
Ramirez, 1999). The modes of action of E are diverse, as it was shown to influence mito-
chondria not only through its nuclear receptors, but also directly binding to mitochondria
in vitro and in situ (Yang et al., 2004; Stirone et al., 2005; Yager and Chen, 2007; Milner
et al., 2008). Some of these effects were not subject to inhibition by classical nuclear ER
antagonists, suggesting a non-genomic pathway of action (Beyer and Raab, 1998; Ivanova
et al., 2001 (MAPK); Ivanova et al., 2002 (PI3K)). However, there is only limited informa-
tion available on interactions between sex steroids and mitochondria, and the underlying
intracellular mechanisms of cell protection by estrogen require further clarification.
1.4.3 Mitochondrial structure
Flexible in shape and size, mitochondria can assume a somewhat spherical to a tubular
form, ranging from 1 to 10 µM in size and from a single to a thousand units in number
inside each cell. Mitochondria are usually organized into a connected and dynamic
network. They are especially abundant in high energy demanding cells, like muscle cells.
Their distribution differs also inside a single cell, accumulating in areas where there is
higher energy demand, such as near the basal membrane, near synapses or at the base of
the flagellum of flagellated cells. This and the extremely ordered structure of mitochondria
in high-energy demanding cells, like in muscle, suggest their form is intimately connected
to their function (Bakeeva et al., 1981; Chen and Chan, 2005).
The mitochondrial double membrane separates the organelle into very different com-
partments in structure, biochemistry and function. The outer membrane is a simple
phospholipid bilayer similar to the cell membrane, containing protein pores that make
it permeable to small molecules like ions, simple nutrients, ATP and ADP. Therefore,
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the intermembrane space, between the two mitochondrial membranes, is similar to the
cytosol, except for higher weight proteins. The inner membrane on the other side, is highly
complex and protein rich. It is folded in cristae which greatly increase the total surface
area, where the complexes for electron transport, the ATP synthase and transport proteins
are organized. The inner room or matrix is a lightly alkaline space with a pH of about
7.7-8.0, housing the enzymes and molecules of the citric acid cycle, the energy carriers and
substrates for the oxidative phosphorilation, mitochondrial ribosomes, tRNA and several
copies of the mitochondrial DNA.
1.4.4 Cellular respiration
To produce energy for the cell, mitochondria extract energy from simple nutrient molecules
like single fatty acid molecules, simple sugars and amino acids. These molecules derive
from organic molecules like fats, carbohydrates and proteins from food, converted into
simpler forms through cytoplasmic and mitochondrial enzymes, in very well described
biochemical pathways (β-oxidation, citric acid or Krebs’ cycle). The set of reactions for
this conversion is called catabolism. Mitochondria are responsible for several essential
functions in metabolism such as fatty acid degradation (β-oxidation), degradation of
metabolites (e.g. urea cycle), biosynthesis of heme-groups, nucleotides and aminoacids.
The transformation of a wide range of molecules to a limited amount of biochemical
forms allows for an optimization of the process. During metabolism, enzymes release
the free energy of nutrients through oxidation, and transfer it to other molecules that
become reduced, in so-called oxidation-reduction or redox reactions. The simple nutrient
molecules generated in the intermediate metabolism, like the Acetyl-Coenzyme A (Acetyl-
CoA), reduced nicotinamide-adenine-dinucleotide (NADH) and reduced flavin-adenine-
dinucleotide (FADH2), are subsequently conveyed to the respiratory chain, which is the last
step of energy production, when the free energy is enough to generate ATP. This last part
of the process consumes oxygen, and the whole is therefore called an aerobic metabolism.
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The elements that process the successive steps of aerobic metabolism constitute the so
called respiratory chain or oxidative phosphorylation system (Fig. 1.1), and are five protein
complexes (I, II ,III, IV and V). Complexes I, III and IV are the H+ translocation machines
that carry H+ from the matrix to the intermembrane space, leading to an electrochemical
gradient, which is essential for the ATP production. The complex V or ATP synthase
allows the H+ to pass through it in the direction of the gradient to produce ATP molecules
from ADP and inorganic phosphate, storing energy as ATP. In the process, oxygen is
needed as the final electron acceptor and therefore, the consumption of oxygen during
the aerobic metabolism is called cellular respiration (Zheng and Ramirez, 1999; Araujo et
al., 2008; Irwin et al., 2008). Interestingly, several studies suggest that mitochondria are
biochemically and functionally diverse in different tissues (Benard et al., 2006) and even
inside the same cell (Kuznetsov et al., 2006) suggesting an adaptation to different demands
of energy at different sites. This is especially interesting in brain energy management,
where different cell types intervene, demanding further research in specific cell types and
their respiratory function.
1.4.5 Mitochondrial dynamics - fusion and fission
Mitochondria usually assume a tubular network morphology, but are present in cells in
different shapes and quantity and also have distinct distributions inside the same cell.
Mitochondria are dynamic organelles, its network being in constant, yet not fully under-
stood, rearrangements. The mitochondrial morphology seems to be controlled by two
opposing and balanced processes: fusion and fission (Figs. 1.2 and 1.3). These processes
of organelle shaping occur far more times than the necessary to maintain mitochondrial
morphology, and are therefore thought to be essential for the proper functioning of mi-
tochondria. In fact, fission is necessary for the even distribution of mitochondria to the
daughter cells during cell division, and is essential in apoptosis (James et al., 2003; Yoon
et al., 2003; Lee et al., 2004; Stojanovski et al., 2004). Fusion, on the other side, serves the
1.4. Mitochondria 13
Figure 1.1: The respiratory chain, also called the oxidative phosphorylation system, is constituted by five
protein complexes (I, II ,III, IV and V). Complexes I, III and IV are the H+ translocation machines that move
H+ from the matrix to the intermembrane space, leading to an electrochemical gradient essential for the ATP
production. The complex V or ATP synthase allows the H+ to pass through it in the direction of the gradient,
that is, to the matrix, to produce ATP molecules from ADP and inorganic phosphate, storing energy.
exchange of carriers and nutrients, and allows for mtDNA molecules exchange, a cleaver
gene complementation strategy, that prevents the detrimental effects of accumulating
mtDNA mutations and cellular dysfunction, until a certain threshold is met (Nakada et al.,
2001). Recent research has revealed several proteins involved in the processes regulating
mitochondrial number and morphology, fusion and fission, each regulated by a specific
set of proteins. Mitochondrial fusion is dependent on mitochondrial GTPases mitofusin
1 and 2 (Mfn1, Mfn2), located in the mitochondrial outer wall and being responsible for
the membrane tethering between two mitochondria during fusion, and dominant optic
atrophy-associated protein (OPA1), an intermembrane protein thought to participate in
the mitochondrial inner membrane fusion and cristae modeling (Fig. 1.2). Mitochondrial
fission on the other hand, is regulated by mitochondrial fission 1 protein (Fis1) an outer
mitochondrial membrane-bound protein, and dynamin-related protein 1 (Drp1, also called
dynamin-like protein 1, Dnm1l), a cytoplasmic protein, recruited to the mitochondrial
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surface during (Fig. 1.3). Fis1 and Drp1 are also responsible for the peroxisome fission,
while their fusion intermediaries are still unclear. Other proteins were found to be involved
in the processes of mitochondrial remodeling, like Ugo1, Rab32 and Mdv1 and there is
currently active investigation to disclose these mechanisms (Santel et al., 2001; Rojo et al.,
2002; Chen et al., 2003; Karbowski et al., 2003; Olichon et al., 2003; Cipolat et al., 2004;
Griparic et al., 2004; Chen and Chan, 2005).
mitochondria
Mfn1/Mfn2
IMM fusion
Opa1
OMM fusion
MITOCHONDRIAL  FUSION
Figure 1.2: Mitochondrial fusion is dependent on the mitochondrial GTPases mitofusin 1 and 2 (Mfn1,
Mfn2) and the dominant optic atrophy-associated protein (OPA1). The mitofusins 1 and 2 are located in the
mitochondrial outer wall and are responsible for the outer mitochondrial membrane (OMM) tethering between
two mitochondria during fusion. OPA1 is an intermembrane protein located at the inner mitochondrial
membrane (IMM) and is thought to participate in the IMM fusion and cristae remodelling, after the OMM
fusion. There are other probable intermediates in this process.
The mitochondrial morphology maintenance is dependent on the equilibrium of these
two opposing and constant processes. An imbalanced expression of fusion or fission
proteins disrupts this equilibrium and causes dramatic changes in mitochondrial mor-
phology leading to dysfunction (Yaffe, 1999; Karbowski and Youle, 2003). In humans,
mutations in Mfn2 cause Charcot-Marie-Tooth neuropathy type 2A (Zuchner et al., 2004;
Kijima et al., 2005) and mutations in OPA1 lead to autosomal dominant optic atrophy
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Figure 1.3: Mitochondrial fission is regulated by mitochondrial fission 1 protein (Fis1) and dynamin-related
protein 1 (Drp1). Fis1, an outer mitochondrial membrane-bound protein, is thought to accumulate in greater
amount at the fission sites. Drp1, a cytoplasmic protein, is recruited to the mitochondrial surface probably
through the action of cofactors. Drp1 molecules are thought to connect to each other in form of a belt, which
tightening provokes the fission of the mitochondria. Other intermediate proteins are probably involved in the
process. After fission, Drp1 is again liberated into the cytoplasm.
(Alexander et al., 2000; Delettre et al., 2000). A down-regulation of fusion proteins or
an over-expression of fission proteins causes fragmentation of the tubular mitochondrial
network. Cells lacking Mfn1 and Mfn2, or OPA1, lacked mitochondrial fusion and showed
severe dysfunctions, such as widespread heterogeneity of mitochondrial membrane poten-
tial, decreased cellular respiration, poor cellular growth, increased susceptibility to cell
death, and apoptosis (James et al., 2003; Yoon et al., 2003; Lee et al., 2004; Chen et al., 2005).
Mfn1 or Mfn2 Knock-out mice dye during embryogenesis, demonstrating the essential role
of mitochondrial fusion in embryonic development and cell viability (Chen et al., 2003).
Small interfering RNA (siRNA) knock-down of OPA1 induced fragmented mitochondria
with dissipation of membrane potential and cristae disassembly, which render highly
sensitized cells to exogenous apoptotic stimuli (Olichon et al., 2003; Griparic et al., 2004;
Lee et al., 2004). In Caenorhabditis elegans, over-expression of fission protein Drp1 increased
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the number of mitochondrial divisions (Labrousse et al., 1999). Fis1 over-expression caused
mitochondrial fragmentation and aggregation (Stojanovski et al., 2004). It is important
to retain that mitochondrial fragmentation does not always result in apoptosis (Lee et
al., 2004). On the other side, over-expression of fusion proteins or down-regulation of
fission proteins stimulates mitochondrial fusion and the development of an elongated
mitochondrial network, inhibiting the apoptosis-related mitochondrial fragmentation and
therefore providing protection against different apoptotic stimuli (Smirnova et al., 2001;
Santel et al., 2003; Sugioka et al., 2004).
1.4.6 Mitochondrial apoptosis regulation
Mitochondria play an essential role in coordinating programmed cell death or apoptosis.
After a death signal, mitochondria divide profusely and release mediators of the apop-
totic signalling. On the onset of apoptosis, the pro-apoptotic Bax translocates from the
cytoplasm to the outer mitochondrial membrane, co-localizing with one of the fission
related proteins, Drp1, on prospective fission sites. Drp1-mediated mitochondrial fission
was found to be the initiating step of mitochondrial outer membrane permeabilization
which leads to the release of cytochrome c, Smac/Diablo and other mediators from the
intermembrane space into the cytoplasm, leading to caspase family proteases activation
and the ignition of the apoptotic cascade (Karbowski and Youle, 2003). Interestingly, Fis1
knock-down by small interference RNA blocked the recruitment and activation of Bax to
the surface of mitochondria after a death stimulus, indicating an essential role for Fis1 in
apoptosis (Lee et al., 2004). Similarly, a loss of Drp1 blocked mitochondrial fission and
cytochrome c release, although it did not significantly interfere with Bax activation (Breck-
enridge et al., 2003; Lee et al., 2004). In the inner side of mitochondria, small interfering
RNA (siRNA) knock-down of OPA1 induced fragmented mitochondria with dissipation
of membrane potential and cristae disassembly, which render highly sensitized cells to
exogenous apoptotic stimuli (Olichon et al., 2003; Griparic et al., 2004; Lee et al., 2004).
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The connection between mitochondrial fusion and apoptosis inhibition through cell
signalling first came from the identification of Mfn2 (previously called hyperplasia sup-
pressor gene, HSG) as an important anti-proliferating protein, interfering with the Ras
pathway and blocking the signalling from growth factor receptors at the plasma membrane
(Chen et al., 2004). Furthermore, the pro-apoptotic protein Bax was found to co-localize
not only with Drp1, but also with Mfn2 on mitochondria during apoptosis (Karbowski
and Youle, 2003) and an activated form of Mfn2 blocked Bax activation and cytochrome
c release, protecting cells from apoptosis (Neuspiel et al., 2005). The over-expression of
fusion proteins or down-regulation of fission proteins stimulates mitochondrial fusion
and the development of an elongated mitochondrial network, inhibiting the apoptosis-
related mitochondrial fragmentation and therefore providing protection against different
apoptotic stimuli (Smirnova et al., 2001; Santel et al., 2003; Sugioka et al., 2004). These
discoveries strongly point towards the importance of the morphological state of mitochon-
dria in relation to their activity and cellular functions, through the involvement of cellular
signalling cascades.
1.5 Aim of this work
Due to the great importance of mitochondrial functions in the cell, and the consequences
of their dysfunction, it is of vital importance to understand the mechanisms underlying
mitochondrial actions and their regulation, and with that simultaneously identify possible
ways to keep proper function. Because mitochondria manage diverse cellular stress and
toxic signals, an improvement of the respiratory energy production and a reduction of
oxidative stress may represent a valid mechanism to stabilize energy homeostasis and to
defend neural cells from death. Generally, an imbalance of the mitochondrial fusion and
fission processes causes mitochondrial and cellular dysfunction indicating that fusion and
fission processes regulating mitochondrial morphology and function are essentially linked
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to cell function and protection or apoptosis.
Steroid hormones regulate many of the cellular processes depending on mitochondria.
Understanding what are the connecting points between them, might clarify the regulation
of those mechanisms and suggest ways to overcome dysfunction and find therapies. Fi-
nally, having an insight of what effects steroid hormones have in mitochondria during
development might enlighten processes of later degeneration and suggest ways to prevent
it or postpone it, possibly improving our quality of life. In an endeavour to better under-
stand the protective action of E and P on mitochondrial related processes, focus was put
on respiration and mitochondrial fusion and fission gene transcription in astrocytes and
an attempt was made to correlate their regulation with cell viability and apoptosis.
The chapters 3 and 4 contain work previously published which was included in this
thesis in accordance with the further authors.
Chapter 2
Materials and methods
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2.1 Reagents
Chemicals were purchased from Roth (Karlsruhe, Germany), while reagents for molecular
biological techniques and cell culture were acquired from Invitrogen (Karlsruhe, Germany),
unless stated otherwise.
2.2 Animals
BALB/c mice were acquired from Harlan Winkelmann GmbH (Borchen, Germany). All
procedures were in strict accordance with the published welfare rules for the care and use
of laboratory animals at the University Clinics Aachen and the government of the State of
Nordrhein-Westfalen, Germany.
2.3 Cell culture
Astrocytes were prepared from postnatal day 1 BALB/c mice (Pawlak et al., 2005). For
separate female or male cell cultures, the gender of the donor was previously determined
by visual inspection of the ano-genital distance which is larger in males, otherwise, mixed
sex cultures were prepared. Brains were isolated and transferred into preparation buffer
consisting of 10 mM HEPES, 154 mM NaCl, 10 mM glucose, 2 mM KCl, and 15 µM bovine
serum albumine (BSA). The desired brain regions, cortex and/or mesencephalon, were
separated and the meninges removed. Afterwards, each brain region was incubated in
PBS containing 0.1% trypsin and 0.02% ethylenediamine-tetraacetic acid (EDTA) for 15
min, minced with a Pasteur pipette and filtered through a 50 µm nylon mesh. The cell
suspension was centrifuged at 300 g (Eppendorf, Hamburg, Germany) for 4 min. The
cell pellet was re-suspended and the cell suspension plated onto poly-L-ornithine-coated
(Sigma-Aldrich, Munich, Germany) culture dishes and cultured in Dulbecco’s modified
Eagle’s medium (DMEM; PAA, Coelbe, Germany) supplemented with 20% (v/v) fetal calf
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serum (PAA, Coelbe, Germany), 50 U/ml penicillin, 50 µg/ml streptomycin, 0.25 µg/ml
amphotericin B (Fungizoner), 2 mM glutamine (Glutamaxr). Cultures were maintained
at 37◦C in a humidified atmosphere of 95% air/5% CO2. Before reaching confluence,
astrocytes were trypsinized and plated at lower density. After the third cell passage,
sub-confluent cells were incubated in neurobasal medium (NBM) supplemented with B27,
penicillin, streptomycin, Fungizoner, and L-glutamine for 48 hours, and then used for
experiments. In some studies the cells were incubated in Neurobasal medium after the
first passage, as indicated in the material and methods section of the applicable chapter.
Astroglial cell cultures prepared from postnatal mouse brains revealed a high yield (>
95%) of GFAP-positive cells as determined by immunocytochemistry against the glial
fibrillary acidic protein (GFAP), a known astrocyte-specific protein marker. Neurons,
oligodendrocytes, and microglia were virtually absent from astrocyte cell cultures (Pawlak
et al., 2005).
2.4 Cell treatments
Astroglial cell cultures placed on culture dishes at 37◦C in a humidified atmosphere in the
presence of NBM were treated with 10−6 or 10−7 M 17β-estradiol (E) and/or progesterone
(P) for different time intervals, as indicated in each of the following chapters. To inhibit
nuclear estrogen receptors or progesterone receptors, cells were pre-treated with 10−6 M
ICI 182,780 (Tocris, Bristol, UK) or RTI 3021-022 (a generous gift from Dr. Trotter, Ulm)
respectively, for 30 min prior and in parallel to E or P treatment.
2.5 Cell viability
To access cell viability under treatments and control conditions, cells were stained with
1 µg/ml Hoechst 33342 (Invitrogen, Karlsruhe, Germany), a fluorescent marker for the
viability of cells, for 5 min under culturing conditions. Subsequently, cells were washed
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twice with PBS, fixed with 4% (w/v) paraformaldehyde (Merck, Darmstadt, Germany)
for 15 min in the dark, at room temperature, and washed twice with PBS. Pictures of the
Hoechst-stained cells were taken from five distinct areas of the same size from each of
the samples of 3-5 independent experiments, with a Hitachi HV-C20A Camera (Tokyo,
Japan) connected to an inverted fluorescence microscope (Leica DMIL, Leica Microsystem,
Wetzlar, Germany) at an excitation wavelength of 365 nm. The labeled nuclei of Hoechst-
stained normal, apoptotic, and necrotic cells were detected accordingly to their specific
morphological characteristics (Horvat et al., 2006). Cells were counted analysing the
pictures taken, by using the software Adobe Photoshop 7.0 (Adobe Systems Inc., USA).
Cell numbers are expressed as a percentage of the total cell number in control conditions,
referred to as 100%. Additionally, cells were stained with propidium iodide to visualize
necrotic astrocytes. Briefly, cells were fixed in 100% (v/v) ice-cold methanol at -20 ◦ C
for 10 min, washed, incubated in a buffer containing 0.3 M NaCl and 0.03 M sodium
citrate, pH 7.0, for 20 min and then stained with 500 nM propidium iodide for 10 min.
Fluorescent necrotic cells were visualized at an excitation wavelength of 535 nm and using
an emission filter of a wavelength > 605 nm and were quantified as described above for
the Hoechst-stained samples.
2.6 Reverse Transcription
Total RNA was isolated from treated and non-treated control astrocytes cultures using
PeqGold RNA pure (PeqLab, Erlangen, Germany), according to the manufacturer’s in-
structions. RNA concentration was measured photometrically using BioPhotometer (Ep-
pendorf). RNA integrity was tested randomly by 1% (w/v) agarose denaturing gel
electrophoresis and ethidium bromide staining and visualized under UV-illumination.
First strand complementary DNA (cDNA) was synthesized from 0.5 µg total RNA. In brief,
total RNA dissolved in 7 µl diethyl pyrocarbonate- (DEPC-) H2O was pre-incubated at
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85◦C for 5 min and placed immediately on ice. Subsequently, the reaction buffer consisting
of 8 U/ µl M-MLV Reverse Transcriptase, 8 mM dithiotreitol, 40 mM Tris-HCl, 60 mM KCl,
and 2.4 mM MgCl2, and 0.4 mM each dNTP (Roti-mixrPCR3, Roth, Karlsruhe, Germany),
was added to the RNA giving a final volume of 12.5 µl. After one hour incubation at 37◦C,
reverse transcription was stopped by heat-inactivating the enzyme at 70◦C for 15 min.
Addition of water instead of RNA served as negative control. Transcripts of 18S rRNA
and the housekeeping gene hypoxanthine guanine phosphoribosyl transferase (HPRT),
spanning over intron-exon borders, served as control for RNA purity and normalization
of sample quantity.
2.7 Semi-quantitative reverse transcriptase - polymerase chain
reaction (sqRT-PCR) analysis
To estimate the mRNA transcript levels of catalytic subunits of the respiratory chain, sqRT-
PCR was performed. 18S rRNA (18S ribosomal RNA) and HPRT (hypoxanthine guanine
phosphoribosyl transferase) served as internal controls and were amplified to normalize
the relative levels of cDNA in different samples. Forward and reverse primers (Tables 2.1
and 2.2) were designed by the author of this thesis for the specific amplification of the
selected genes of interest: mitochondria-encoded subunits of the respiratory chain ND1
(complex I, NADH ubiquinone oxidoreductase, subunit 1), cytB (complex III, ubiquinol
cytochrome c oxidoreductase), cox2 (complex IV, cytochrome c oxidase, subunit 2), ATP6
(complex V, ATP synthase, subunit 6), the mitochondrial fusion and fission intermediaries
mitofusin 1 (Mfn1), mitofusin 2 (Mfn2), fission 1 homolog (Fis1), dynamin-related protein
1 (Drp1, also called dynamin 1-like protein, Dnm1l), a proliferation marker, proliferating
cell nuclear antigen (PCNA), an anti-apoptotic marker, B-cell lymphoma protein 2 (Bcl2),
and a pro-apoptotic marker, Bcl2-associated X protein (Bax). For each set of primers, a
basic local alignment search tool (BLAST, NCBI) search revealed that sequence homology
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was obtained only for the target gene.
Table 2.1: Primer information for the mitochondrial-encoded respiratory chain subunits and the mitochon-
drial fusion and fission intermediaries.
Gene Genbank accession Primer sequence 5’-3’
Mitochondrial-encoded respiratory chain subunits
ND1 NC 005089.1 TTTACGAGCCGTAGCCCAAA
GGCCGGCTGCGTATTCTAC
CytB NC 005089.1 ACGAAAAACACACCCATTATTT
CCGTTTGCGTGTATATATCGGATT
Cox2 NC 005089.1 AACCGAGTCGTTCTGCCAAT
AACCCTGGTCGGTTTGATGTT
ATP6 NC 005089.1 AGCAGTCCGGCTTACAGCTAA
GGAGGGTGAATACGTAGGCTTG
Mitochondrial fusion and fission intermediaries
Mfn1 NM 024200 CAG AGA AGA GGG TTT ATT CA
ACT CAT CAA CCA AAA CAG AT
Mfn2 NM 133201 TGA ATG TTG TGT TCT TTC TG
AAG TGC TCT CTG CTA AAT GT
Fis1 NM 025562 AGA TGG ACT GGT AGG CAT GG
CTA CAG GGG TGC AGG AGA AA
Drp1 NM 152816 TTT GCT CGT GTG AAG ACT GG
TCC TGG AGC TTC CTT TCT GA
To establish optimal PCR conditions, a linear regression analysis was performed for
all the genes of interest as well as for the housekeeping genes, 18S rRNA and HPRT, at
a range of 12-38 cycles under standard conditions. Analysis of the sqRT-PCR products
revealed single bands for all cDNAs of catalytic subunits at the correct molecular weight
(see table 2.3). The cycle numbers applied in the sqRT-PCR analysis met the requirements
of linear regression for each gene. Optimal cycle numbers between 20 and 32 for all
genes studied reflected approximately 50-70% of maximal OD values obtained at 38 cycles,
when gene amplification became saturating. This guaranteed that all mRNAs of interest
were analysed within the linear PCR amplification range and suitable for further semi-
and quantitative gene expression studies. As primers for HPRT were designed as intron
over-spanning gene sequences, the observation of a single band for HPRT indicated that
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the isolated RNA and subsequently the synthesized cDNA were free of genomic DNA
impurities.
Table 2.2: Primer information for the markers of apoptosis and proliferation and the internal housekeeping
controls.
Gene Genbank accession Primer sequence 5’-3’
Markers for apoptosis and proliferation
Bcl2 BC089016 CAT CCC AGC TTC ACA TAA CC GCA
ATC CGA CTC ACC AAT AC
Bax NM 007527 GGC AGA CAG TGA CCA TCT TT AGG
GGA CCT GAG GTT TAT TG
PCNA X53068 TTT TTC ACA AAA GCC ACT CC
TCA GGA GCA ATC TTC AAA GG
Internal controls
HPRT NC 000086.6 GCTGGTGAAAAGGACCTCT
CACAGGACTAGAACACCTGC
18S rRNA X00686 CGG CTA CCA CAT CCA AGG AA
GCT GGA ATT ACC GCG GCT
The PCR reaction was performed in a reaction buffer containing 0.032 U/µl Taq DNA
polymerase, 1.5 mM MgCl2, 150 mM Tris-HCl, 60 mM KCl, 0.2 mM dNTPs, and 0.2 µM
primers (Sigma Genosys, Steinheim, Germany) for 0.75 µl of cDNA of each gene of interest
in a total volume of 12.5 µl. The negative control contained water instead of cDNA. The
PCR conditions (Table 2.3) for the respiratory chain subunits of interest started with an
initial denaturation at 95◦C for 5 min followed by 20 (ATP6) or 26 (ND1, cytB, cox2)
amplification cycles composed of 95◦C for 45 s, 53◦C for 45 s, and 72◦C for 60 s, and ended
with a final elongation of 5 min at 72◦C. The PCR conditions for the mitochondrial fusion
and fission genes of interest was similar, only the amplification cycles varied: 26 (Bcl2) or 30
(Mfn1, Mfn2, Fis1 and Drp1) cycles composed of 95◦C for 45 s, 53◦C (Mfn1, Mfn2) or 58◦C
(Fis1, Drp1) and 72◦C for 60 s. The PCR for the internal control genes 18S rRNA and HPRT,
and for the proliferation marker (PCNA), anti-apoptotic marker (Bcl2), and pro-apoptotic
marker (Bax) was again similarly constructed, with specific amplification cycles (Table 2.3):
14 (18S rRNA), 26 (Bcl2), 28 (HPRT) or 32 (PCNA, Bax) amplification cycles composed
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of 95◦C for 45 s, 59◦C (Bcl2, Bax, PCNA) 60◦C (18S rRNA) or 61◦C (HPRT) for 45 s, and
72◦C for 60 s. The PCR products were then separated together with a semi-quantitative
DNA marker ladder, E-Gelr low range quantitative DNA ladder by a 1.5% (w/v) agarose
gel electrophoresis containing ethidium bromide, and visualized under UV-illumination
(AlphaImagerr, Alpha Innotech, Biozym Scientific GmbH, Oldendorf, Germany). Semi-
quantitative analysis of the PCR product bands normalized to the quantitative gel marker
bands was performed using AlphaEaseFCTM Software (Alpha Innotech Corporation 2003).
Results of at least three independent experiments normalized against the internal controls
are presented as percentage of control.
Table 2.3: Polymerase Chain Reaction (PCR) details: annealing temperature, cycle number and product
size.
Gene Annealing temperature Cycle number Product size (bp)
Mitochondrial-encoded respiratory chain subunits
ND1 53◦C 26 260
CytB 53◦C 26 246
Cox2 53◦C 26 155
ATP6 53◦C 20 182
Mitochondrial fusion and fission intermediaries
Mfn1 53◦C 30 191
Mfn2 53◦C 30 164
Fis1 57◦C 30 211
Drp1 58◦C 30 241
Markers for apoptosis and proliferation
Bcl2 59◦C 26 175
Bax 59◦C 32 228
PCNA 59◦C 32 194
Internal controls
HPRT 61◦C 28 250
18S rRNA 60◦C 14 186
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2.8 Quantitative real time-PCR (qRT-PCR) analysis
Quantitative real-time PCR (qRT-PCR) analysis of the genes of interest was performed
using SYBRr Green technology and carried out on the iQ5 detection system (Bio-Rad,
Munich, Germany). Standard and sample cDNA obtained after reverse transcription (see
above) were diluted 1:10 and added to a solution containing 5 µM primers and IQ SYBR
Green Supermix (Bio-Rad, Munich, Germany) consisting of 25 U/ml iTaq polymerase,
50 mM KCl, 20 mM Tris-HCl, 0.2 mM each dNTP, 3 mM MgCl2, SYBR Green I and
stabilizers. Using a standard curve of cDNA dilutions the amount of sample cDNA was
quantified. The qRT-PCR protocol was composed of an initial denaturation step for 3 min
at 95◦C followed by 40 cycles consisting of 10 s at 95◦C, 30 s at the appropriate annealing
temperature for the target gene (Table 2.3), 30 s at 72◦C, and 10 s at 78◦C. To obtain melting
curves for the resulting PCR products, a final step was added to the qRT-PCR consisting of
81 cycles for 10 sec each stepwise increasing the cycle temperature by 0.5◦C, beginning with
the cycle 1 at 55◦C and ending with cycle 81 at 95◦C. The threshold cycle (Ct) for real-time
quantitative PCRs is reported as the cycle at which a significant increase in fluorescence
takes place. Ct values change linearly with increasing target amount. The PCR products
were quantified using the relative ∆Ct method. Relative quantification relates the PCR
signal of the target transcript to that of HPRT in treated with respect to untreated cells.
A test for an approximately equal efficiency of target amplification was performed by
looking at how the ∆Ct value varies with template dilutions. 18S rRNA and HPRT served
as endogenous control in the validation experiments. The absolute value of the slope of
log input amounts versus ∆Ct should be less than -3.3 and the efficiency approximately
100%. The validation experiments passed this test. The results are expressed as the average
of at least three samples of three independent experiments for control and treated cells.
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2.9 Measurement of mitochondrial and nuclear DNA
To quantify the amount of mitochondria in a defined number of E/P treated versus control
astroglial cells, the content of mitochondrial DNA was taken as an indirect measure for
the mitochondrial mass. Total DNA was extracted using DirectPCR lysis reagent (Viagen
Biotech, Los Angeles, USA) by incubating cells for 5 h at 55◦C and subsequent inactivation
of the enzyme reaction at 85◦C for 45 min. The suspension was then used for PCR of the
mitochondrial marker gene ATP6 (17 cycles at 53◦C) and HPRT as a nuclear control gene
(28 cycles at 61◦C). The results are expressed as the ratio of ATP6 to HPRT expression in
steroid-treated cells, as a percentage of control (untreated cells).
2.10 Isolation of mitochondria from primary astrocytes
Mitochondria were isolated from primary astrocytes in the previously described culture
conditions (see section 2.3). Treated and control cells from culture dishes (about 1x108 as-
trocytes) were collected by scraping the cells from the dish surface and precipitating them
by centrifugation at 300 g (Eppendorf 5415R) for 4 min. The cell pellet was re-suspended
in 1 ml ice-cold isotonic mitochondrial isolation buffer consisting of 0.25 M sucrose, 5
mM HEPES, and 1 mM EDTA. Suspended cells were homogenized in a pre-cooled plastic
vessel with pestle (Eppendorf). To precipitate nuclei and cell fragments the disrupted
cells were centrifuged at 500 g for 10 min at 4◦C. The resulting supernatant was trans-
ferred into a pre-cooled tube, while the pellet was re-suspended in 500 µl mitochondrial
isolation buffer for a second turn of homogenization to optimize mitochondria isolation.
Both supernatants were collected and centrifuged at 9400 g for 15 min at 4◦C. The pellet
containing mitochondria was re-suspended in 22 µl mitochondrial buffer and kept on ice
for the duration of the experiments.
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2.11 Polarographic measurements
Mitochondria were isolated as described above (section 2.10), from primary cortical and
mesencephalic astrocytes after E treatment and under control conditions. Mitochondria
were kept on ice during polarographic measurements. Respiration of isolated mitochondria
was measured polarographically at 25◦C in a volume of 500 µl of a buffer consisting of 70
mM sucrose, 220 mM mannitol, 2 mM HEPES, 5 mM MgCl2, 5 mM KH2PO4, 1 mM EDTA.
The measurements were conducted after subsequent additions of 20 µM rotenone, 10 mM
succinate, 30 µM ADP (state 3 mitochondrial respiration), and 3 µM carbonyl cyanide m-
chlorophenylhydrazone (CCCP; uncoupled mitochondrial respiration), using an Oxygraph
system (Helmut Saur Laborbedarf, Reutlingen, Germany). The activity of mitochondria is
given as Turnover Number (TN) which is the consumed O2 (µM) / [(time (min) x total
amount of protein (mg)]. TN was determined at state 3 (in the presence of ADP) and state 4
(after ADP has been phosphorylated reflecting ATP-dependent mitochondrial respiration)
respirations as well as at the uncoupled state of mitochondrial respiration. The Respiratory
Control Ratio (RCR), an index of the electron transport chain coupling, was calculated as
the ratio of state 3 to state 4 respiration rates.
2.12 Protein content determination
The protein content of isolated mitochondria was measured applying the Bio-Rad Dc
Protein Assay (Munich, Germany) microtiterplate procedure according to the manufac-
turer’s protocol. Samples of frozen mitochondria were solubilised in mitochondrial buffer
resulting in a 1:5 dilution of original mitochondrial samples, sonicated for 30 sec using
Bransonic 52 ultrasonic bath (Branson, Soest, Netherlands) and then used for the protein
assay. Samples that were centrifuged prior to the protein assay gave the same results as
those that were not. BSA served as standard.
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2.13 Statistical analysis
Data are presented as the mean ± SEM of at least three to five independent experiments.
For statistical analysis, data was analyzed by applying ANOVA followed by a posthoc
Student’s unpaired t-test and regarded as statistically significant at P≤0,05. The statistical
significance was further divided into sections P<0,05, P<0,01 and P<0,001 according to
their fit.
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Chapter 3
Steroid hormone effects on
mitochondrial respiration
Estrogen regulates mitochondrial gene expression and respiratory
chain activity in cortical and mesencephalic astrocytes1
1Adapted from: Araujo, Beyer and Arnold 2008. Journal of Neuroendocrinology 20, 930-941.
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Abstract
The regulation of mitochondrial energy metabolism plays an essential role in the CNS. Abnormalities of the
mitochondrial respiratory chain often accompany neurodegenerative diseases. This makes mitochondria
a perfect target for strategies of cellular protection against toxic compounds and pathological conditions.
Steroid hormones, such as estrogen, are well-known to fulfil a protective role in the brain during ischemic
and degenerative processes. Since astrocytes function as the major energy supplier in the CNS, the estrogen
effects on the mitochondrial respiratory chain of this cell type were here analysed. In these studies, semi-
and quantitative PCR analysis of gene expression and polarographic measurements of the respiratory chain
activity of mitochondria were applied. It was observed that structural and functional properties were
regulated dependent on the estrogen exposure time and the brain region but independently of the nuclear
estrogen receptors were observed. These studies demonstrate that long-term estrogen exposure increases
the subunit gene expression of respiratory chain complexes and the mitochondrial DNA content, thereby
indicating an up-regulation of the amount of mitochondria per cell together with an increase of mitochondrial
energy production. This could represent an important indirect mechanism by which long-term estrogen
exposure protects neurons from cell death under neurotoxic conditions. On the other hand, short-term effects
of estrogen were observed on the activity of mitochondrial, proton-pumping respiratory chain complexes.
In astrocytes from cortex, respiratory chain activity was decreased, whereas it was increased in astrocytes
from mesencephalon. An increased production of reactive oxygen species would be the consequence of
an increased respiratory chain activity in mesencephalic astrocytes. This could serve as an explanation for
different efficiencies of estrogen-mediated short-term protection in distinct brain regions, but indicates also
the limitations for a therapeutic short-term application of estrogen.
3.1 Introduction
Estrogen, a steroid sex hormone, affects numerous physiological processes in the central nervous system
(CNS), such as the early embryonic cell differentiation and modulation of motor and cognitive processes
(Mendez et al., 2005; Daniel, 2006). Beside these, estrogen exhibits neuroprotective properties in the
embryonic and adult brain, preventing nerve cells from oxidative stress, toxic factors, and chemically induced
apoptosis (McEwen, 1992; Beyer, 1999; Harms et al., 2001; Behl, 2002; Garcia-Segura, 2001; Kajta and Beyer,
2003; Kipp et al., 2006). In the CNS, astrocytes play an important role in mediating the effects of estrogen.
They represent not only the direct target cells for estrogen, but are also of major importance for mediating
neural cell protection (Behl, 2002; Kipp et al., 2006; Dhandapani and Brann, 2007). Estrogen-induced changes
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of physiological parameters occur via interactions with nuclear and non-nuclear estrogen receptors (ER)
that appear to be essential for estrogen-dependent gene expression and activation of various intracellular
signalling pathways (Garcia-Segura, 2001; Kajta and Beyer, 2003; Beyer and Raab, 1998; Collins and Webb,
1999; Behl, 2003; Beyer et al., 2003). Previously, estrogen was also found to interact with mitochondria
(Chen et al., 2004; Yang et al., 2004). Because mitochondria function as integrators of diverse cellular stress
and toxic signals (Greenamyre et al., 1999; Reynolds, 1999; Choo et al., 2003; Beal, 2005), an improvement
of energy production and a reduction of oxidative stress may represent a valid mechanism to stabilize
energy homeostasis and to defend neural cells from death. In this context, estrogens have repeatedly been
reported to play an important role in the regulation of mitochondrial function, such as energy metabolism,
cell signalling, calcium homeostasis, and apoptosis (Behl, 2002; Kipp et al., 2006; Chen et al., 2004; Bettini and
Maggi, 1992). However, the underlying intracellular mechanisms of neuroprotection by estrogen are not fully
understood. This raises the question of how estrogen may regulate mitochondrial function. One possibility
is to control expression of mitochondrial proteins encoded by the nuclear genome involving the activation of
classical nuclear estrogen receptors. Another possibility is to regulate mitochondrial genes or to directly
modify enzyme activity of respiratory chain complexes. Supporting both pathways, the first evidence came
from studies by Bettini and Maggi (1992) and Law et al.(1994), which have shown that oestradiol treatment is
associated with increased transcript levels of mitochondrial (mt) DNA- and nuclear (nc) DNA-encoded genes
for mitochondrial respiratory chain proteins. The screening of a cDNA library from the hippocampus of
estrogen-stimulated ovariectomized rats identified subunit III of complex IV of the mitochondrial respiratory
chain as a target gene of estrogen (Bettini and Maggi, 1992). Furthermore, the non-classical signalling of
estrogen is a wide-spread phenomenon. It was shown that mitochondrial cytochrome c oxidase subunit III
expression was induced in the midbrain through non-classical steroid signalling mechanisms (Bjorklund and
Lindvall, 1984). These direct and rapid interactions of estrogen with mitochondria may play an important
role in the control of cellular energy homeostasis. A signalling pathway regulating mitochondrial function
and involving a direct interaction of estrogen with mitochondria is indicated by mitochondrial location of
ERs in hippocampal neurons and cerebral blood vessels (Chen et al., 2004; Yang et al., 2004; Stirone et al.,
2005). However, the exact mechanism of the regulation of astrocytic mitochondria remains unknown. In the
present study, data is presented on the regulation of catalytic subunit expression of the proton translocating
respiratory chain complexes by estrogen. It is shown that estrogen induced an up-regulation of mRNA
transcripts of catalytic respiratory chain subunits affecting respiratory chain activity. These results suggest
that estrogen influences cellular energy homeostasis via a long-term action of estrogen by up-regulating the
expression of catalytic subunits and also via a short-term action by directly affecting mitochondrial ATP
production, both through non-classical estrogen signalling mechanisms.
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3.2 Materials and Methods
For information on the materials and methods used in this study, please refer to Chapter 2. For information
on the author’s contributions please refer to Contributions. In this investigation, cells were treated with 10−6
M 17β-estradiol (E2, generally referred to as estrogen, E) for 4, 8, 12 or 24 hours, as described in the figure
legends.
3.3 Results
3.3.1 Regulation of the expression of catalytic respiratory chain sub-
units by estrogen
The expression of catalytic subunits of the mitochondrial respiratory chain complexes was assessed in
primary neonatal mouse mesencephalic and cortical astroglial cell cultures. Immunocytochemical analysis
for glial fibrillary acidic protein (GFAP) revealed a high yield (> 95%) of GFAP-positive astrocytes, whereas
neurones, oligodendrocytes, and microglia were virtually absent from the astroglial cell cultures. This is in
accordance with previous studies (for further details please see Chapter 2).
To determine whether estrogen regulates the gene expression of catalytic respiratory chain subunits,
one representative mitochondrial gene was selected for each of the mitochondrial proton translocating
respiratory chain complexes: ND1 (complex I, NADH ubiquinone oxidoreductase), cytB (complex III,
ubiquinol cytochrome c oxidoreductase), cox2 (complex IV, cytochrome c oxidase, COX), ATP6 (complex
V, ATP synthase). Firstly, the expression of these genes was analysed, by applying a qualitative, semi-
quantitative RT-PCR technique (sqRT-PCR; for information on the methods and materials used, please refer
to Chapter 2). To establish optimal PCR conditions, linear regression analysis was performed for ND1, cytB,
cox2, ATP6, as well as for the housekeeping genes, 18S rRNA and HPRT, at a range of 12-32 cycles under
standard conditions. Analysis of the sqRT-PCR products revealed single bands for all cDNAs of catalytic
subunits at the correct molecular weights. The cycle numbers applied in our sqRT-PCR analysis met the
requirements of linear regression for each gene. Optimal cycle numbers between 20 and 28 for all genes
studied reflected approximately 50-70% of maximal optical density values obtained at 38 cycles, when gene
amplification became saturating. This guaranteed that all mRNAs of interest were analysed within the
linear PCR amplification range and suitable for further semi- and quantitative gene expression studies. As
primers for HPRT were designed as intron over-spanning gene sequences, the observation of a single band
for HPRT indicated that the isolated RNA, and subsequently the synthesized cDNA, were free of genomic
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DNA impurities (for further information, please refer to Chapter 2).
The preliminary qualitative studies on cultured astrocytes from cortex and mesencephalon revealed
that all mitochondrial genes of interest are expressed in considerable amounts. This is in accordance to the
observation of mitochondria organelles and mitochondrial activity in these cells (see below). To study the
effect of estrogen on the expression of catalytic subunits of the mitochondrial respiratory chain in astroglial
cell cultures, the optimal concentration and time range of estrogen treatment had to be established. Primary
astrocytes were treated with different concentrations of 17β-estradiol (E2) between 10−10 and 10−6 molar
and tested for significant changes of the catalytic subunit expression. A significant up-regulation of mRNA
was observed for all catalytic subunits (ND1, cytB, cox2, ATP6) at all E2 concentrations tested (data not
shown). For further studies, micromolar E concentrations were chosen as to cover all potential pathways
of E action (i.e. classical and non-classical ER signalling as well as direct interactions of E with proteins).
Thus, primary astrocytes from cortex and mesencephalon were treated with 10−6 M E2 for different time
intervals. Subsequently, the mRNA expression of catalytic subunits of respiratory chain complexes was
assessed by sqRT-PCR and compared with the expression profile of the housekeeping genes, 18S rRNA and
HPRT, which served as control set 100% (Fig. 3.1).
The results show a maximal observed increase (20-50%) for the expression of ND1 (complex I), cytB
(complex III), cox2 (complex IV), and ATP6 (complex V) after 8 and 12 hours of E treatment of cortical (Figs.
3.1 A) and mesencephalic
astrocytes (Figs. 3.1 B), respectively. ND1 and cox2 were up-regulated by ca. 20 and 40%, respectively,
in astrocytes from both brain regions. Brain region-specific differences were observed for E-induced up-
regulation of the catalytic subunits cytB and ATP6. In cortical astrocytes, cytB and ATP6 were increased by
16±5% and 29±2%, respectively (Fig. 3.1 A), whereas mesencephalic astrocytes showed an elevation of cytB
by 51±16% and ATP6 by 56±15% (Fig. 3.1 B). This indicates that the E-induced up-regulation of cytB and
ATP6 is more pronounced in mesencephalic astrocytes than in cortical astrocytes.
To substantiate the semi-quantitative gene expression results, a quantitative RT-PCR (qRT-PCR) analysis
followed. HPRT expression values served as control and were set to 100%. The qRT-PCR data analysis
revealed an up-regulation of the catalytic respiratory chain subunits cytB by 13±8%, cox2 by 28±14%,
and ATP6 by 86±27%, except for ND1 expression which showed a down-regulation by 37±1% in cortical
astrocytes (Fig. 3.2 A, darker bars). In mesencephalic astrocytes, gene expression of all catalytic subunits
was increased (Fig. 3.2 B, darker bars). ND1 transcript levels were elevated by 41±29%, cytB by 43±11%,
cox2 by 42±12%, ATP6 by 101±48%. Comparing astrocytes from two different brain regions, qRT-PCR and
sqRT-PCR both revealed increase of catalytic subunit expression that was more pronounced in mesencephalic
than in cortical astrocytes. An E exposure time for longer than 8 h and 12 h for cortical and mesencephalic
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Figure 3.1: Time course of estrogen (E) effects on the expression of catalytic subunits of the mitochondrial
respiratory chain. Cortical astrocytes (A) and mesencephalic astrocytes (B) in culture were incubated in the
presence of 10−6 M 17β-estradiol for 4, 8, 12, 24 h. Total RNA was isolated and first strand cDNA was
synthesized for ND1, cytB, cox2 and ATP6 in a sqRT-PCR. Data were normalized to housekeeping genes
18S rRNA and HPRT and represent means ± SEM of three independent experiments of three different cell
preparations. Statistically significant differences (* - P<0.05, ** - P<0.01, *** - P<0.001) between samples
were determined using Student’s unpaired t-test.
astrocytes, respectively, did not show any further increase in gene expression. Therefore, these time ranges
were applied for further investigations of the E effects on mitochondrial function.
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To determine whether the nuclear ERs would be involved in regulating mitochondrial gene expression,
the ER antagonist ICI 182.780 was applied to astroglial cell cultures 30 min prior to and throughout the E
treatment. The simultaneous application of an ER antagonist did not interfere with the observed E effect
on catalytic respiratory chain gene expression in astrocytes from both brain regions (Fig. 3.2 C, D). This
observation is in line with our expectations indicating that E stimulates mitochondrial gene expression
independently of the nuclear estrogen receptor pathway.
3.3.2 Effect of Estrogen on the ratio of mitochondrial versus nuclear
DNA levels
An up-regulation of mRNA transcripts of catalytic respiratory chain subunits could be paralleled, on
one hand, by regulation of mitochondrial activity, and, on the other hand, by elevation of the amount of
mitochondria per cell. The latter could be reflected by an overall increase of mitochondrial protein and/or
mitochondrial DNA content. To assess the effect of E on the amount of mitochondria in astrocytes, the
ratio of mitochondrial DNA to nuclear DNA was measured in a defined number of astroglial cell cultures
from cortex and mesencephalon before and after E2 treatment at a concentration of 10−6 M for 8 and 12
h, respectively. In Fig. 3.3, a significant increase of the mitochondrial versus nuclear DNA content by
22±13% becomes evident in cortical astrocytes, whereas mesencephalic astrocytes show a greater elevation
by 54±15%.
3.3.3 Long-term estrogen effects on mitochondrial activity
On the basis of these gene expression studies, it is proposed here that there is a concomitant change of
mitochondrial activity. To determine whether there would be a correlation between an increased expression
of mitochondrial catalytic respiratory chain subunits and mitochondrial respiratory activity by E, the
subsequent measurement of the succinate-stimulated respiration of isolated intact mitochondria from E-
treated in comparison to control astrocytes from cortex and mesencephalon followed. After E treatment,
cortical and mesencephalic astrocytes were incubated in NBM for an additional 4h to allow translation
of mRNA transcripts and protein targeting into mitochondria (Strausberg and Butow, 1977; Barrientos
et al., 2004). Subsequently, intact mitochondria were isolated from E-treated and -untreated cortical and
mesencephalic astroglial cell cultures. Respiratory chain activity was measured immediately thereafter by
assessing mitochondrial oxygen consumption stimulated by addition of succinate as substrate. Unexpectedly,
significant changes were observed neither for mitochondrial respiration of mitochondria from E-treated
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Figure 3.2: Effect of estrogen (E) on the expression of catalytic subunit genes of the mitochondrial respiratory
chain complexes. Primary astrocytes from cortex (A, C) and mesencephalon (B, D) in culture were incubated
in the presence of 10−6 M 17β-estradiol for 8 and 12 h, respectively. Total RNA was isolated and first strand
cDNA was synthesized. Figures A and B show the results of a semi-quantitative sqRT-PCR (left bars in
light grey) and a quantitative qRT-PCR (right bars in dark grey) using a Bio-Rad iQ5 detection system
(Munich, Germany). The expression of the catalytic subunits ND1 (complex I), cytB (complex III), cox2
(complex IV), ATP6 (complex V) was analysed in E-treated astrocytes from cortex (A) and mesencephalon
(B), normalized to HPRT and 18S rRNA as housekeeping genes and related to the expression in untreated
control astrocytes set 100% (C). The qRT-PCR data were analyzed using the relative ∆Ct method. Figures C
and D represent a sqRT-PCR analysis of the expression levels of Cox2 (lighter bars) and ATP6 (darker bars)
of cortical (C) and mesencephalic (D) astrocytes treated with 10−6 M 17β-estradiol (estrogen, E) and 10−6
M 17β-estradiol plus 1 µM ICI 182.780 (E+ICI) normalized to housekeeping genes and related to that in
untreated control astrocytes set 100% (C). Data represent means± SEM of three independent experiments of
three different cell preparations. Statistically significant differences (* - P<0.05, ** - P<0.01, *** - P<0.001)
between samples were determined using Student’s unpaired t-test.
versus untreated cortical and mesencephalic astrocytes stimulated by succinate, ADP, or CCCP (Figs. 3.4 A,
C, E and B, D, F, respectively), nor for the efficiency of mitochondrial energy production determined as RCR
(Figs. 3.4 G and H, respectively). With respect to the low RCR values of approximately 1.4-1.8, which suggest
that mitochondria were uncoupled, the ADP/O ratio was additionaly calculated, as another parameter of
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Figure 3.3: Effect of estrogen (E) on the ratio of mitochondrial to nuclear DNA content in cortical (A) and
mesencephalic (B) astrocytes. Mitochondrial and nuclear DNA contents were determined as an indirect
measure for the amount of mitochondria in a defined number of 10−6 M 17β-estradiol-treated versus control
astroglial cells. Total DNA was extracted using DirectPCR lysis reagent (Viagen Biotech, Los Angeles,
USA). The suspension has directly been used for PCR of the mitochondrial gene ATP6 and HPRT as a
nuclear control gene. The results are expressed as the ratio of ATP6 versus HPRT expression in E-treated
cells normalized to control cells set 100%. Statistically significant differences (* - P<0.05) between samples
were determined using Student’s unpaired t-test.
mitochondrial integrity. ADP/O ratios were in the range 1.1-1.4, which is indicative of coupled mitochondria
respiration stimulated with succinate.
Similar results were obtained in preliminary experiments applying glutamate/malate as mitochondrial
energy substrates (data not shown). However, comparing the succinate-, ADP-, and CCCP-stimulated
respiration of mitochondria from cortical with those from mesencephalic astrocytes, an up to two-fold higher
activity of mitochondria isolated from cortical astrocytes can be observed.
3.3.4 Short-term estrogen effects on mitochondrial respiratory chain ac-
tivity
To distinguish E-induced long-term effects of several hours of E exposure on mitochondrial protein expres-
sion from the short-term effects of several minutes of exposure which could affect mitochondrial activity
directly, isolated intact mitochondria were incubated in the presence of 10−6 M E2 for 5 and 30 min prior
to the measurement of mitochondrial activity. This revealed a significant decrease by 28±9% of succinate-
stimulated respiration of cortical astrocyte mitochondria, whereas mesencephalic astrocyte mitochondria
showed an increase of respiration by 57±30% after E treatment of isolated mitochondria for 5 min (Figs. 3.5
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A, B). The same tendency was observed after 30 min of E2 exposure for succinate-stimulated respiration
of astrocyte mitochondria from cortex (decrease by 15±9%) and mesencephalon (increase by 33±16%).
ADP-stimulated (state 3) and uncoupled (CCCP-stimulated) mitochondrial respiration did not show any
significant changes for cortical astrocytes (Figs. 3.5 C, E), whereas for mesencephalic astrocyte mitochondria,
a significant increase of state 3 mitochondrial activity by 52±8% and 40±14% (Fig. 3.5 D) and an elevation of
uncoupled mitochondrial activity by 30±12% and 28±16% were measured after 5 and 30 min of E2 treatment,
respectively (Fig. 3.5 F). The RCR values remained unchanged for cortical and mesencephalic astrocyte
mitochondria after micromolar E treatment of intact mitochondria (Figs. 3.5 G, H).
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Figure 3.4: Long-term effects of estrogen (E) on the mitochondrial respiration. Intact mitochondria were
isolated from primary cortical (graphics on the left side, A, C, E, G) and mesencephalic astrocytes (graphics on
the right side, B, D, F, H) after 8 and 12 h of 10−6 M 17β-estradiol treatment and further 4 h incubation on
NBM. (A) Succinate respiration of intact mitochondria was measured polarographically at 25◦C in a buffer
containing 70 mM sucrose, 220 mM mannitol, 2 mM HEPES, 5 mM MgCl2, 5 mM KH2PO4, 1 mM EDTA.
The measurements were conducted after subsequent additions of 20 µM rotenone, 10 mM succinate (A, B), 30
µM ADP (C, D), and 3 µM CCCP (E, F) using an Oxygraph system (Helmut Saur Laborbedarf, Reutlingen,
Germany). The activity of mitochondrial respiration is given as Turnover Number (TN, consumed µM O2 /
min x mg of total protein). The Respiratory Control Ratio (RCR) value (G, H) was calculated as the ratio
of respiration state 4 to state 3. Data represent means ± SEM of three independent experiments of three
different cell preparations. Statistically significant differences between samples determined using Student’s
unpaired t-test were not observed.
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Figure 3.5: Short-term effects of estrogen (E) on the mitochondrial respiration. Intact mitochondria were
isolated from primary cortical (graphics on the left side, A, C, E, G) and mesencephalic (graphics on the right
side, B, D, F, H) astrocytes. Immediately after isolation, mitochondria were incubated in the absence (control)
and presence of 10−6 M 17β-estradiol for 5 and 30 min prior to the measurement of mitochondrial activity at
25◦C. Subsequently, the succinate respiration of intact mitochondria was assessed applying the Oxygraph (for
details, see Fig. 3.4). The measurements were conducted after subsequent additions of 20 µM rotenone, 10
mM succinate (A, B), 30 µM ADP (C, D), and 3 µM CCCP (E, F). The activity of mitochondrial respiration
is given as Turnover Number (TN, consumed µM O2 / min x mg of total protein). The Respiratory Control
Ratio (RCR) value (G, H) was calculated as the ratio of respiration state 4 to state 3. Data represent means ±
SEM of three independent experiments of three different cell preparations. Statistically significant differences
(* - P<0.05) between samples were determined using Student’s unpaired t-test
.
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3.4 Discussion
In the present study, two different (long- and short-term) effects of E can be observed on mitochondria
in astroglial cells cultured from mouse brain cortex and mesencephalon. Numerous reports allocate that
neurones and non-neuronal cells are target cells for E (Behl, 2002; Kipp et al., 2006; Dhandapani and Brann,
2007; Beyer et al., 2003). Astrocytes express estrogen receptors (ER) α and β in the cortex as well as in the
mesencephalon (Beyer et al., 2003). In addition to the predominant nuclear staining, various degrees of
cytoplasmic staining for both ERα and ERβ are evident in a variety of tissues and cells including various brain
cell types (Li et al., 1997; Simonian and Herbison, 1997; Price and Handa, 2000; Zhang et al., 2002; Mitra et al.,
2003; Pawlak et al., 2005). Supporting the direct effects of E on mitochondria, earlier reports have suggested
an association of E-binding capacity and E-binding proteins with mitochondria (Grossman et al., 1989; Monje
and Boland, 1999; Moats and Ramirez, 2000; Monje et al., 2001; Mitra et al., 2003). Monje and Boland, (1999)
and Monje et al., (2001) provided more direct evidence for the presence of ERα and ERβ in mitochondria
from rabbit uterus and ovary tissue. More recently, Chen et al. (2004) demonstrated the localisation of ERα
and ERβ to mitochondria in MCF7 cells and related the presence of ERs in mitochondria to the mediation of
functional effects caused by E treatment. However, there are no reports to date demonstrating a functional
role of an E interaction with astrocyte mitochondria. Therefore, the respiratory activity of mitochondria is
here investigated, along with the regulation of mitochondrial gene expression after E treatment of astrocytes.
These studies revealed that E affects mitochondrial function in a time- and concentration-dependent manner
reaching maximal effects at a E concentration of 10−6 µM and after 8 and 12 h for cortical and mesencephalic
astrocyte mitochondria, respectively. The long-term effects were reflected by elevated mtDNA levels in
astrocytes from cortex and mesencephalon accompanied by increased transcript levels of mtDNA-encoded
catalytic subunits of the respiratory chain. Both effects indicate an elevation of mitochondrial mass per
cell, especially because, under these conditions, astrocyte proliferation remained unaffected by E (data not
shown). Furthermore, increases in mtDNA have previously been proposed to serve as a feedback mechanism
that compensates for a decline in respiratory chain function (Kim et al., 2004).
Besides the long-term effects on mitochondrial gene transcription, here are shown short-term (5, 30 min)
effects of micromolar E concentrations on the respiratory chain activity in a brain region-specific manner.
With regard to E-mediated signalling mechanisms, it has been reported (Dhandapani and Brann, 2002;
Beyer et al., 2002; Beyer et al., 2003; Kipp et al., 2006) that E is capable of regulating gene expression in
cultured neurones and astrocytes by two different mechanisms, i.e., classically through nuclear receptors and
non-classically through the stimulation of membrane-E receptors which are coupled to distinct intracellular
signal transduction cascades. This is substantiated by the presence of nuclear as well as mitochondrial
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ERs in astrocytes from both brain regions studied. The observations presented here were well in line with
reports about increased levels of mtDNA- and ncDNA-encoded subunits of complex IV in rat brain cells,
hepatocytes, human Hep G2 cells etc. (Chen et al., 2004; Bettini and Maggi, 1992; Demonacos et al., 1996;
Chen et al., 2003; Hsieh et al., 2006). However, by contrast to these reports, there was no detection of any
inhibitory effect of ICI182,780, a pure ER antagonist, on the elevation of mitochondrial gene transcription
(Chen et al., 2004; Stirone et al., 2005) in this study. Therefore, the classical nuclear ER pathway is excluded
as a regulatory mechanism for mitochondrial genes, proposing the stimulation of a non-classical signalling
pathway for cortical and mesencephalic astrocytes. However, a potential involvement of mitochondrial ERs
in the regulation of mitochondrial genes needs to be further elucidated along with the exact mechanism of
E-stimulated up-regulation of respiratory chain subunit expression.
The E concentration used in this study (10−6 M) might at first glance appear to be above physiological
relevant E levels. Nevertheless, several previous in vitro studies also show a requirement of higher E
concentrations to generate physiological effects (Pawlak et al., 2005; Banerjee et al., 1997; Luconi et al., 1999;
Ivanova et al., 2002; Rune et al., 2006; Von Schassen et al., 2006). Intriguingly, the brain itself produces E by
means of the aromatase activity (Mukai et al., 2006; Prange-Kiel et al., 2006). This possibly allows higher
tissue steroid concentrations in the brain than in the blood plasma (Schumacher et al., 2003). Preliminary
data using mass spectrometry to reach highest sensitivity revealed that juvenile mouse brain tissue contains
several-fold higher estrogen levels compared to the corresponding plasma values. These findings suggest that
the concentration chosen for the in vitro experiments described here may reflect the in vivo situation rather
than being non-physiologically high. In addition, transient expression of the E-forming enzyme aromatase at
varying concentrations may contribute to region-specific differences in E concentrations affecting differently
the expression of E-regulated genes (Prange-Kiel et al., 2006). Besides, some reports indicate an antioxidant
role for E, especially when applied at micromolar pharmacological concentrations (Culmsee et al., 1999;
Moosmann and Behl, 1999; Sugishita et al., 2003; Nilsen and Brinton, 2004). With regard to the aromatic
nature of the E2 molecule, which promotes penetration of lipid membranes and scavenging free radicals, it
should be taken into account that protective short-term E effects on mitochondrial respiratory chain function
could be paralleled or initiated by this antioxidant pathway.
Interestingly, the up-regulation of the catalytic subunit transcription of mitochondrial respiratory chain
complexes by long-term exposure of cortical and mesencephalic astrocytes to E were not paralleled by any
obvious significant changes of mitochondrial activity or efficiency of energy production (Fig. 3.4). This is in
contradiction to numerous observations demonstrating an activation of mitochondrial respiratory activity
by E. For example, E treatment of ovariectomized female rats caused an increase of the transcript levels of
mtDNA- and ncDNA-encoded subunits of complex IV accompanied by increased enzyme and mitochondrial
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respiratory chain activity in cerebral blood vessel mitochondria (Stirone et al., 2005). In vitro studies showed
similar results (Chen et al., 2003). Nilsen and Brinton (2004) demonstrated an E-mediated increase of
the oxidative phosphorylation that would preserve ATP levels in neurones and increase mitochondrial
respiration efficiency. These effects are likely to be enhanced by antioxidant effects of estrogen. The possible
reasons for the apparent discrepancy include: (i) very low RCR values impeding the detection of changes
in the efficiency of mitochondrial respiration; (ii) an up-regulation of mitochondrial gene expression not
being paralleled by an elevation of nuclear gene expression of mitochondrial proteins in astrocytes; (iii)
the increase in mRNA expression not necessarily being translated into an increase of protein synthesis in
astrocytes; and (iv) a different isoform expression pattern of regulatory subunits of the respiratory chain
complexes causing a decrease instead of the expected increase of mitochondrial activity. With respect to
point (i), the RCR values measured here of approximately 1.4-1.8 were very low. Despite the fact that other
studies (Almeida and Medina, 1997; Benard et al., 2006) also reported relatively low RCR values of 1.7
and 2.6 for astrocytes and brain mitochondria stimulated by succinate and pyruvate/malate, respectively,
which support the results presented here, RCR values of 9-10 for astrocyte mitochondria have been recently
reported (Kristin et al., 2006). Low RCR values are an indicator for at least partially uncoupled mitochondria.
There could be several reasons for the discrepancy in RCR values obtained by different groups. Compared to
Kristin et al., (2006), the methods for the isolation of mitochondria and the measurement of state 4 respiration,
which is directly implicated in the RCR calculation, differed. Furthermore, the accumulation of residual
traces of CCCP, although the electrode chamber was washed thoroughly after applications of the uncoupler
CCCP, cannot be excluded. As an additional parameter of the integrity of isolated mitochondria, the ADP/O
ratio was determined. Calculated ADP/O values for mitochondria isolated from estrogen-treated and
untreated astrocytes were in the range 1.1-1.4. Similar values were reported in several other studies for
a coupled mitochondrial respiration stimulated by succinate (Hafner et al., 1998; Gnaiger et al., 2000).
Interestingly there weren’t any significant differences for the ADP/O ratios of mitochondria from treated
and untreated cells (data not shown). To further substantiate the present data, intact cell respiration studies
were performed. The preliminary data showed a stimulating effect of long-term estrogen treatment of
astrocytes on mitochondrial activity, which will be subject to further investigations. To rule out reason
(ii), the analysis of the nuclear-encoded COX subunit IV gene expression reflected an up-regulation of
the transcript (data not shown, incorporated into another submitted manuscript). Furthermore, as the
measured mitochondrial activity was normalized to the whole mitochondrial protein content, an increase
of mitochondrial activity due to an increased expression of specific genes might be camouflaged by an
increased overall mitochondrial protein content and would not be evident from the normalized respiration
rates. Supporting this assumption, an increase in mtDNA was detected, which could be an indication for the
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mitochondrial protein content being increased along with the amount of mitochondria per cell. That would
suggest a higher mitochondrial activity due to a higher number of mitochondria and a larger mitochondrial
protein amount in E-treated versus untreated cells. This increase in respiratory activity would lead to a
higher ATP production that could meet high energy consuming processes in astrocytes, especially when
cells undergo stress conditions. This might also explain why cells treated with E prior to a toxic stimulus
(e.g. MPP+) show a higher survival rate than cells not being treated with E (Bains et al., 2007). In the same
context, it is shown here an up to two-fold higher succinate-, ADP-, and CCCP-stimulated mitochondrial
respiration for cortical astrocytes compared with mesencephalic astrocytes that occurred independently of
the E treatment. This suggests that cortical astrocytes are more protected from energy deprivation than
astroglia from mesencephalon by sustaining higher levels of energy production. Nevertheless, mitochondrial
respiration coupling is dependent on the membrane conditions of the isolated mitochondria, and another
attempt was made to prove the intactness of the isolated mitochondria, using scanning electron microscopy,
SEM (many thanks to D. Alves) and the pictures produced show well kept membranes, inclusively very clear
inner membrane invaginations (Fig. 3.6), which show that a fair degree of intactness of the mitochondria is
kept. This is supported by the proposed 3D model of mitochondrial imaging of Manella (Manella, 2000).
Even though isolated mitochondria do not compare to mitochondria in physiological conditions, their form
resembles one of the mitochondria forms depicted by others, described as smaller, elliptical mitochondria
with randomly disposed cristae appearing to be floating free in the inner compartment (Ambu et al., 2000).
Isolated mitochondria have been described since decades as small and spherical to elliptical. During the
extraction, which obliges to the breakage of cells and necessarily, breakage of the mitochondrial net, the
method cannot preserve mitochondria in their original physiological structure.
Figure 3.6: Isolated mitochondria scanning electron microscopy, SEM. Mitochondria were isolated according
to the description in Chapter 2, section 2.10. Cryofraction SEM was performed by D. Alves, many thanks.
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To study the short-term pathways of E signalling, 1 µM E2 was applied for 5 and 30 min on intact mito-
chondria isolated from mouse brain cortical and mesencephalic astroglial cells. This short-term application
of E exerted a brain region-specific increase of succinate-stimulated oxygen consumption of mitochondria
from mesencephalic, but not from cortical astrocytes which showed a decrease of mitochondrial respira-
tion (Fig. 3.5). The ADP- and CCCP-stimulated respiration in the presence of succinate as substrate also
demonstrated an increase in astrocyte mitochondria from mesencephalon, but no changes in astrocyte
mitochondria activity from the cortex. Interestingly, the RCR values remained unchanged for mitochondria
from astrocytes of both brain regions. This indicates that short-term E treatment of astrocytes does not
influence the efficiency of mitochondrial energy production, but affects the activity of proton-translocating
complexes of the respiratory chain. As the short-term E treatment of intact mitochondria leads neither to
an up-regulation of the expression of ATP synthase subunits (data not shown), nor does E stimulate ATP
synthase activity in astrocytes (Kipp and Ramirez 2001), no compensation for a higher proton-translocating
activity of complexes I, III, and IV by a faster consumption of the increased proton gradient can occur.
Zheng and Ramirez (1999) support this aspect by showing that E at micromolar concentrations inhibits
F0F1-ATPase activity by binding to the oligomycin-sensitivity conferring protein (OSCP), a subunit of the
ATP synthase that is required for coupling the proton gradient to ATP synthesis. Thus, the increase of the
succinate respiration in mitochondria from mesencephalic astrocytes is an indicator of a hyperpolarisation
of the mitochondrial membrane potential, which, in turn, causes a higher production of reactive oxygen
species (ROS) by the complexes III and I of the respiratory chain (Lee et al., 2001; Kadenbach et al., 2004). As
indicated by the ADP-stimulated respiratory chain activity in the presence of succinate, this effect is even
more pronounced under conditions when cellular ATP levels are low and energy production becomes crucial
for cell survival. Therefore, the observed elevation of respiratory chain activity might be concomitant with
increased deleterious ROS production, specifically in mesencephalic astrocytes. This would indicate that a
short-term E treatment is less effective for improvement of mitochondrial function and survival of astrocytes
in the mesencephalon, whereas E protects cortical astrocytes by decreasing mitochondrial respiratory chain
activity to a level where ROS production does not occur. It might be that a decrease of succinate-stimulated
respiration paralleled by a decrease of oxygen consumption is a mechanism to prevent ROS production.
This may, at least in part, explain why astrocytes from mesencephalon are more prone to be subject to cell
death induced by toxic and stress factors than astrocytes from cortex. However, the extent to which each of
these mechanisms contributes to the overall protective defence state initiated by E remains to be elucidated
further.
In summary, this study shows that E influences mitochondrial physiology independently of the nuclear
ERs in a long- and short-term manner. There weren’t any significant long- or short-term effects of E on the
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efficiency of mitochondrial energy production. However, after long-term E treatment of astrocytes from both
brain regions, an elevated mitochondrial gene expression and mtDNA content was observed, which can be
considered as a measure of the amount of mitochondria per cell. This is presumably accompanied by an
increase in the activity of proton-translocating and proton-consuming respiratory chain complexes leading
to increased ATP levels but lower ROS production in astrocytes. In turn, this would support the survival
of astrocytes undergoing stress and degenerative processes by providing them with higher energy levels.
The results described here emphasize the neuroprotective role of E in long-term treatment of astrocytes
in different brain regions and could represent an important indirect mechanism by that estrogen protects
neurons from cell death under neurotoxic conditions. Interestingly, cortical astrocytes, independent of
estrogen treatment, showed higher mitochondrial respiration rates than mesencephalic astrocytes. This
indicates a higher level of protection of astrocytes from brain cortex compared with mesencephalon. Short-
term E treatment showed different effects on the respiratory chain activity in astrocytes from cortex and
mesencephalon. This could, at least in part, explain why cortical astrocytes are better preserved from stress
conditions and degenerative processes than astrocytes in the mesencephalon during short-term E exposure.
However, to better understand the in vivo role of E, the time and concentration range of E would need to
be measured under physiological and pathological conditions. Nevertheless, these studies indicate that a
short-term application of micromolar E concentrations appears to be protective for cortical astrocytes.
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Chapter 4
Steroid hormone effects on
mitochondrial fusion and fission
Gender-specific regulation of mitochondrial fusion and fission gene
transcription and viability of cortical astrocytes by steroid hormones2
2Adapted from: Arnold, Wright Araujo and Beyer 2008. Journal of Molecular Endocrinology 41, 289-300.
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Abstract
Astroglia and steroid hormones such as estrogen and progesterone regulate cell growth, function, and pro-
tection in the central nervous system (CNS). It appears that astrocytes and steroids act in concert to promote
cell survival under pathological conditions. With respect to the role of mitochondrial fusion and fission in
energy metabolism, apoptosis, and proliferation, astrocyte mitochondria resemble a perfect intracellular
target for steroids to modulate these processes, thereby promoting cell vitality after damage. Here focus was
put on the effects of estrogen and progesterone on cell viability in comparison with mitochondrial fusion and
fission gene transcription in primary cortical astrocytes from female and male mouse brains. Estrogen- and
progesterone-treated female astrocytes demonstrated an increase in cell number and proliferation marker
accompanied by an upregulation of fusion and fission gene transcription, which were apparently balancing
pro- and anti-apoptotic processes. On the other hand, male astrocytes exhibited no change in cell number
after estrogen treatment, but a decrease after progesterone administration. This could be the consequence
of stimulated apoptosis in male astrocytes by both steroids, which was counterbalanced by an increased
proliferation in the presence of estrogen, whereas it was strengthened in the presence of progesterone.
Supportively, estrogen promoted and progesterone decreased the transcription of fusion and fission genes.
It seems that estrogen and progesterone affect mitochondrial fusion and fission gene transcription in cortical
astrocytes in a gender-specific way, thereby influencing mitochondrial function differently in both genders.
Thus, interaction of sex steroids with mitochondria may represent one possible cause for gender differences
in cellular pathology in the CNS.
4.1 Introduction
Estrogen (E) and progesterone (P) exert their well-known neuroprotective effects in the CNS by initiating a
multitude of cellular mechanisms which are often mediated by astrocytes (Azcoitia et al., 2002; Arnold, 2005;
Pawlak et al., 2005; Garcia-Segura and Melcangi, 2006; Leonelli et al., 2007). Astrocyte mitochondria represent
an interesting intracellular target organelle for steroid hormones, since they provide ample of services to
neural cells including energy production, calcium buffering, and regulation of apoptosis. These processes
are also known to be modulated by gonadal steroid hormones (Nilsen and Brinton, 2004; Kipp et al., 2006).
However, mitochondria-mediated mechanisms in steroid-dependent protection are not fully understood. In
very recent studies, it has been shown that E promotes the expression of mitochondria-encoded subunits
of the respiratory chain, thereby influencing mitochondrial respiratory activity and enhancing functional
efficiency (Araujo et al., 2008; Irwin et al., 2008). Mitochondrial functions are not only affected by regulation
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of gene expression and activity of the respiratory chain (Zheng and Ramirez, 1999; Araujo et al., 2008; Irwin
et al., 2008), but also by the morphology of these organelles. Two sets of proteins and their relative activities
are involved in shaping the morphology of mitochondria. While mitochondrial GTPases, mitofusin 1 and 2
(Mfn1, Mfn2) and optic atrophy 1 homolog (Opa1), are essential for fusion processes, fission 1 (mitochondrial
outer membrane) homolog (Fis1) and dynamin-related protein 1 (Drp1) are essential fission proteins (Santel
and Fuller, 2001; Rojo et al., 2002; Chen et al., 2003; Olichon et al., 2003; Griparic et al., 2004; Cipolat et al.,
2004; Chen and Chan, 2005). Given the highly ordered arrangement of mitochondrial networks in some
cell types (Bakeeva et al., 1981), it is likely that mitochondrial shape indeed has important consequences
for mitochondrial function. Under physiological conditions, mitochondria are characterized by a dynamic
equilibrium of fusion and fission, whereas an imbalanced expression of fusion versus fission proteins
leads to a disturbance of this equilibrium and causes dramatic changes in mitochondrial morphology and
function (Yaffe, 1999; Karbowski and Youle, 2003). In humans, mutations in Mfn2 cause Charcot-Marie-Tooth
neuropathy type 2A (Zuchner et al., 2004; Kijima et al., 2005). Mutations in Opa1 lead to autosomal dominant
optic atrophy (Alexander et al., 2000; Delettre et al., 2000). A down-regulation of fusion proteins together
with an impairment of mitochondrial fusion processes or an over-expression of fission proteins causes
fragmentation of the tubular mitochondrial network (James et al., 2003; Olichon et al., 2003; Yoon et al., 2003;
Lee et al., 2004; Stojanovski et al., 2004; Chen et al., 2005; Detmer and Chan, 2007). As a consequence, an
increased susceptibility to cell death and apoptosis occurred. Knock-out mice of either Mfn1 or Mfn2 are
both embryonic lethal demonstrating the essential role of mitochondrial fusion for embryonal development
and cell viability (Chen et al., 2003). In contrast, over-expression of the two mitofusin proteins together
provides some protection against different apoptotic stimuli (Sugioka et al., 2004). On the other hand,
mitochondrial fission proteins (Fis1 and Drp1) and processes are essential for cell division as well as for
programmed cell death and decreased cell survivability (James et al., 2003; Yoon et al., 2003; Lee et al., 2004;
Stojanovski et al., 2004). In Caenorhabditis elegans, an over-expression of fission protein Drp1 increased the
number of mitochondrial divisions (Labrousse et al., 1999). Fis1 over-expression also caused mitochondrial
fragmentation and aggregation (Stojanovski et al., 2004). On the contrary, a disruption of fission by over-
expressing a mutant form of Drp1 or over-expression of fusion proteins provoked an elongation and
formation of interconnected mitochondrial network due to enhanced mitochondria fusion (Smirnova et al.,
2001; Santel et al., 2003). Considering the severe consequences of imbalanced mitochondrial fusion and
fission for neurodegeneration, the effect of E and P on the transcription level of mitochondrial fusion and
fission genes in cortical astrocytes in vitro was studied. Astrocytes were elected, for being an outstanding cell
type in the CNS supporting neuronal viability and function. It is apparent that neurodegenerative processes
and their steroid responsiveness often occur in a gender-specific way (Miller et al., 1998; Roof and Hall, 2000;
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Dluzen and McDermott, 2004; Kenchappa et al., 2004; Marchetti et al., 2005). Therefore, female and male
astroglia were analysed separately.
4.2 Materials and Methods
For information on the materials and methods used in this study, please refer to Chapter 2. For information
on the author’s contributions please refer to Contributions. In this investigation, cells were treated with 10−7
M 17β-estradiol (E2, generally referred as E) or progesterone (P) for 24 h.
4.3 Results
4.3.1 Gender-specific effects of steroid hormones on cell viability and
apoptosis
In a first attempt, the gender-specific effects of E- and P-treatment on proliferation and apoptotic death of
cortical astrocytes were analysed. Female and male astrocyte cultures were treated with 10−7M E or P in
the absence or presence of the appropriate receptor inhibitor, i.e. ICI and RTI as inhibitors for ER and PR,
respectively. Viable, apoptotic, and necrotic astrocytes were distinguished by fluorescent labelling of cell
nuclei with Hoechst 33342. Before and after treatments, no significant changes in the number of necrotic cells
were detected (0-2 cells per total number of approx. 100 cells; data not shown). This finding was supported
by experimental data obtained from propidium iodide staining which labels necrotic cells (data not shown).
Due to the fact of a constant number of necrotic astrocytes, focus was put on the determination of the number
of viable and apoptotic astrocytes before and after hormone application. Treatment of cortical astrocytes from
female brains with E or P for 24 h induced a significant increase in the number of Hoechst-stained viable
cells by approximately 50% (Fig. 4.1 A). Co-application of P and PR inhibitor suppressed this effect, whereas
the ER inhibitor did not affect the E-mediated effect (Fig. 4.1 A). Independently of the steroid hormone
applied, the number of apoptotic cells was not significantly changed in female astrocyte cultures (Fig. 4.1 C).
In contrast, the application of E did not exert any effect on the number of viable male cells, whereas P caused
a decrease (Fig. 4.1 B). The latter effect was counteracted by RTI. Compared to female astrocytes, opposite
effects were observed concerning apoptosis of male astrocytes. Both hormones provoked a significant 3- to
4-fold induction which was partially suppressed by ICI and completely antagonized by RTI (Fig. 4.1 D).
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Figure 4.1: Effect of estrogen (E) and progesterone (P) on the viability (A, B) and apoptotic cell death (C,
D) of female and male cortical astrocytes. Primary astrocyte cultures from female (A, C) and male (B, D)
Balb/c mice were treated with 10−7 M E or P or co-treated with 10−6 M of the appropriate inhibitors of
steroid receptors ICI 182.780 (ICI for ER) and RTI 3021-022 (RTI for PR) for 24 h. The number of viable
astrocytes (A, B) and apoptotic cells (C, D) were scored after staining astrocyte nuclei with Hoechst 33342.
Data represent the percentage of the ratio of sample cell numbers to untreated control cell numbers referred to
as 100% as means ± SEM of triplicates of five independent experiments. *p<0.05, **p<0.01, ***p<0.001,
E-/P-treated samples versus untreated controls; #p<0.05, ##p<0.01, inhibitor plus E-/P-treated samples
versus E-/P-treated samples.
In a next step, the transcription levels of pro-, anti-apoptotic, and proliferation markers (Bax, Bcl2, and
PCNA, respectively) where measured, to assess if changes in the viable and apoptotic cell numbers resemble
changes in the marker gene expression. Primers used for RT-PCR amplification (Chapter 2, section 2.7) were
designed as intron over-spanning sequences except for 18S rRNA. Only single bands at correct molecular
weight (Chapter 2, Table 2.3) were observed for the PCR products of the housekeeping gene HPRT and the
genes of interest in an agarose gel. This indicates that the isolated RNA was free of genomic DNA impurities.
In female cortical astrocytes, E exerted no significant effect on the transcription of anti- and pro-apoptotic
marker genes, whereas P induced an approximately 6-fold up-regulation of Bcl2 and Bax transcription
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Figure 4.2: Effect of estrogen (E) and progesterone (P) on the transcription of apoptosis and proliferation
markers in cortical astrocytes. Cultured astrocytes from female (A,C) and male (B, D) brains were treated
with 10−7 M E or P in the absence or presence of 10−6 M ICI or RTI for 24 h. Specific quantification of Bcl-2
(A, B; lighter columns) and Bax transcripts (A, B; darker columns) as well as PCNA transcripts (C, D)
was performed by RT-PCR. Data were normalized to 18S rRNA and HPRT. Untreated astrocytes from the
same cell culture preparation served as negative control and were set 100%. Data represent the percentage
of control expressed as means ± SEM of triplicates of five independent experiments. *p<0.05, **p<0.01,
***p<0.001, E-/P-treated samples versus untreated controls; #p<0.05, ##p<0.01, ###p<0.001, inhibitor
plus E-P-treated samples versus E-P-treated samples.
(Fig. 4.2 A), which was partially down-regulated by RTI. Unlike females, male astrocytes responded to E
application with an increased transcription of the apoptotic marker Bax and a decrease of anti-apoptotic Bcl2
(Fig. 4.2 B). Treatment of male astrocytes with P caused a decreased transcription of both marker genes. The
P effect was completely inhibited by RTI, whereas ICI reversed only the E effect on Bcl2 transcription.
In female astrocytes, PCNA transcription was 5- to 8-fold up-regulated, irrespective of the hormone
(Fig. 4.2 C). Once more, ICI did not prevent the E effect, but RTI partially abolished the P effect. PCNA
transcription levels in male astrocytes were stimulated by E, but significantly down-regulated by P (Fig. 4.2
D). ICI did not interfere with E’s effect while RTI antagonized P’s effect.
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4.3.2 Gender-specific effects of steroid hormones on fusion and fission
gene transcription
After treatment of female and male cortical astrocytes with E or P, the transcription levels of Mfn1, Mfn2,
Fis1, and Drp1 were determined by RT-PCR (Fig. 4.3). In female astrocytes, E stimulated Mfn2 but not
Mfn1 transcription, whereas P exposure caused an increase of both fusion transcripts (Fig. 4.3 A). In male
astrocytes, E decreased Mfn1 but increased Mfn2 transcription, whereas P down-regulated both fusion gene
transcript levels (Fig. 4.3 B). Regarding fission gene transcription, in female astrocytes, E and P stimulated
both Drp1 and Fis1 (Fig. 4.3 C). In male astrocytes, E also increased Drp1 and Fis1 transcription, but P
decreased the transcription of both fission genes (Fig. 4.3 D). Looking at the receptor inhibitors effects, in
female astrocytes, ICI did not antagonize the E effects whereas RTI partially blocked the P effect (Figs. 4.3 A,
C). In male astrocytes, ICI blocked only the E effect on Mfn1 transcription, and RTI reversed the P effect on
the transcription of all fusion and fission genes (Figs. 4.3 B, D).
Correlation analyses of Mfn1 with Bcl2 transcripts and Drp1 with PCNA for female and male astrocytes
are given in Figures 4.4 A-D. It becomes evident that Mfn1 correlates well with Bcl2 and Drp1 with PCNA
for both steroid hormones and both genders (Figs. 4.4 A, B and C, D, respectively) by showing similar
transcription levels. Several observations concerning gender-specific differences of the hormonal regulation
deserve attention: (i) In females, P increased Mfn1, Bcl2, Drp1 and PCNA transcript levels (Figs. 4.4 A, C); in
males, gene transcription was decreased (Figs. 4.4 B, D). (ii) Treatment of astrocytes with E caused higher
transcript levels of Mfn1, Bcl2, Drp1 and PCNA in females than in males (Figs. 4.4 A, C versus 4.4 B, D). In
females, Mfn1 and Bcl2 are not changed by E, but decreased in males. Drp1 and PCNA are increased by E in
females to a greater extent than in males.
A possible correlation of the ratios of Drp1/Fis1 transcription and PCNA/Bax transcription with
viable/apoptotic cell number is shown in figures 4.5 A and B for female and male astrocytes, respectively.
When comparing all three ratios, the following gender-specific differences become clear: (i) The PCNA/Bax
transcript level and viable/apoptotic cell ratios are > 1 for female astrocytes treated with E or P, whereas
these levels are < 1 for the same treatments in male astrocytes; (ii) The Drp1/Fis1 ratios are decreased in P-
treated versus E-treated male astrocytes, but slightly increased in females. Generally, for both genders: (i) the
ratios of PCNA/Bax are decreased in P-treated compared to E-treated cells; (ii) the ratios of viable/apoptotic
cell numbers do not differ between the two steroid treatments.
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Figure 4.3: Effect of estrogen (E) and progesterone (P) on the transcription of mitochondrial fusion and
fission genes in cortical astrocytes from female and male brains. Primary cortical astrocytes from female (A,
C) and male (B, D) mouse brains were incubated in the presence of 10−7 M E or P for 24 h. Antagonists of
estrogen and progesterone receptors (ICI and RTI, respectively) were added simultaneously to the respective
steroid hormone treatment. Specific quantification of fusion genes, Mfn1 (A, B; lighter columns) and Mfn2
(A, B; darker columns), and fission genes, Drp1 (C, D; lighter columns) and Fis1 (C, D; darker columns)
was performed by RT-PCR. Data were normalized to 18S rRNA and HPRT and related to the transcription
levels in untreated control astrocytes set 100%. Data represent the percentage of control as means ± SEM of
triplicates of five independent experiments. *p<0.05, **p<0.01, ***p<0.001, E-/P-treated samples versus
untreated controls; #p<0.05, ##p<0.01, inhibitor plus E-/P-treated samples versus E-/P-treated samples.
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Figure 4.4: Correlation analysis between Mfn1 and Bcl2 gene transcription (A, B) as well as Drp1 and
PCNA gene transcription (C, D) in female (A, C) and male (B, D) astrocytes. Data used for this graph
derived from Figures 4.2-4.3. Gene transcription levels for Mfn1 (A, B; lighter columns) and Bcl2 (A,
B; darker columns) as well as for Drp1 (C, D; lighter columns) and PCNA (C, D; darker columns) after
E/P-treatment in the absence or presence of ICI/RTI for 24 h are presented as % of control set 100%. Note
that P exerted opposite effects in female and male astrocytes. Treatment of astrocytes with E caused higher
transcription levels of all four genes in females (A, C) compared to males (B, D).
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Figure 4.5: Correlation analysis between the ratios of Drp1/Fis1 transcription levels (Drp1/Fis1), PCNA/Bax
transcription levels (PCNA/Bax), and viable/apoptotic cell numbers (Viab/Apop) for female (A) and male (B)
astrocytes. Gender-specific differences become obvious when comparing the ratios of Drp1 to Fis1 (lighter
grey columns) with those of PCNA to Bax (darker grey columns) or with the ratios of viable to apoptotic cell
number (darker columns). Note that the PCNA/Bax transcripts and viable/apoptotic cell ratios are > 1 for
female astrocytes treated with E or P (A), whereas these levels are < 1 for E-/P-treated male astrocytes (B).
For both, female (A) and male (B) astrocytes, the ratios of PCNA/Bax are decreased in P-treated compared
with E-treated cells, whereas the Drp1/Fis1 ratios are also decreased in P-treated versus E-treated male
astrocytes, but marginally increased in females. The ratios of viable/apoptotic cell numbers do not differ
between the two steroid treatments neither in females (A) nor in males (B). a.u., arbitrary units.
4.4 Discussion
Astrocytes are essential for the support of neurons in the CNS (Pellerin et al., 2007; Schousboe et al., 2007).
They are implicated in the regulation of growth, cell proliferation, and neuroprotection in the brain (Beyer,
1999; Beyer et al., 2003; Garcia-Segura et al., 2003; Kajta and Beyer, 2003; Kipp et al., 2006; McCarthy, 2008).
In the past years, the neuroprotective aspects of E and P effects in the CNS have been studied using in vitro
and in vivo approaches. Besides direct interactions of E and P with neurons (Kipp et al., 2006; Stein et al.,
2008), there are indications that neurons may be indirectly protected through other cells. However, estrogen
has consistently been demonstrated to be protective in vivo and in organotypical cultures (Dhapandani and
Brann, 2002; Simpkins et al., 2005). This suggests the involvement of another non-neuronal brain cell type
exerting a protective function. Of these, astrocytes have the greatest potential for a possible involvement in
neuroprotection. Astrocytes are the most abundant type of glial cells in the brain and are located juxtaposition
to neurons, outnumbering them by a 10:1 ratio in the cortex. This cell type might most probably have a
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critical role in steroid-mediated protection of neurons in the brain, since ablation of astrocytes in vivo results
in a significant decrease of neuronal survival (Cui et al., 2001). Astrocytes are also well-described target
cells for E and P, expressing the corresponding nuclear steroid receptors (Jung-Testas et al., 1992; Santagati
et al., 1994; Beyer, 1999; Quadros et al., 2007). Confirming previously published data (Pawlak et al., 2005),
transcripts for ERα, ERβ, and PR were observed in cortical astrocytes from both genders. Besides the above
described supportive function, astrocytes play a major role for the energy homeostasis of the brain, pointing
at astrocyte mitochondria as an interesting compartment involved in neuroprotection. However, there is only
limited information available on interactions between sex steroids and mitochondria. Recent studies have
shown that E promotes the expression of mitochondria-encoded subunits of the respiratory chain, thereby
influencing mitochondrial respiratory activity and enhancing functional efficiency (Araujo et al., 2008; Irwin
et al., 2008). Mitochondrial functions are not only affected by regulation of nuclear and mitochondrial gene
expression and activity of the respiratory chain (Zheng and Ramirez, 1999; Araujo et al., 2008; Irwin et al.,
2008), but also by the morphology of these organelles. It is noteworthy that E influences mitochondria not
only through its nuclear receptors, but acts also directly by binding of E to mitochondria in vitro and in situ
(Yang et al., 2004; Stirone et al., 2005; Yager and Chen, 2007; Milner et al., 2008). Interestingly, some effects, in
particular those exerted by E but not by P, were not subject to inhibition by classical nuclear ER antagonists.
Proliferation and fission gene transcription were obviously mediated by E via non-classical mechanisms
in male and female astrocytes. The context of mitochondrial fission and cell division additionally supports
the role of one for the other. Such a proliferative E action that is intracellularly transmitted through, for
instance, the MAP kinase system has already been reported for non-neural cells (Bouskine et al., 2008).
This is in line with a previous observation of a rapid activation of ERK in astroglia (Ivanova et al., 2001).
Intriguingly, a recent report suggests a mitochondrial ER-mediated pathway in stimulation of cell division
(Chen et al., 2008). Besides proliferation, the ER antagonist ICI did not abolish any of the E effects on female
astrocytes studied, whereas in male astrocytes, ICI prevented the E effects by decreasing apoptotic cell death
and increasing Bcl2 and Mfn1 transcription. This indicates gender-specific E actions in the context of anti-
apoptotic processes and an involvement of Mfn1 therein. It is known that a wide range of neurodegenerative
disorders show distinct sex-specific differences in course and incidence. Thus, a female prevalence is known
for Alzheimer’s disease and multiple sclerosis, whereas a male prevalence was observed for Parkinson’s
disease and stroke. In particular, intact adult female rodents sustain lower mortality and less neuronal
damage as compared to age-matched male rodents following middle cerebral artery occlusion (Alkayed
et al., 1998). Parkinson’s disease reveals a clear gender disparity (Shulman, 2007). Interestingly, estrogen
appears to exert opposite effects in females and males in an experimental animal model for Parkinson’s
disease being neuroprotective only in females (Gillies et al., 2004). Estrogen replacement therapy leads to
4.4. Discussion 65
an improvement of Parkinsonian symptoms of women in the menopause (Shulman, 2007). Both disorders,
stroke and Parkinson’s disease, are characterized by a disruption of mitochondrial function (Singh et
al., 2006; Thomas and Beal, 2007; Poole et al., 2008; Schapira, 2008). This raised the question whether
steroid-mediated regulation of mitochondrial morphology and function could be involved in the gender-
specificity of neurodegenerative and neuroprotective processes. Besides functional characteristics, such as
energy production, the morphology of mitochondria including the expression of fusion and fission genes
are indicators of mitochondrial vitality. Increased fusion processes cause an elongation of mitochondria,
whereas a raise in fission leads to mitochondrial fragmentation (Chan, 2007). Generally, an imbalance of
mitochondrial fusion and fission causes mitochondrial and cellular dysfunction indicating that fusion and
fission processes are essentially linked to cell function and protection/apoptosis. In an attempt to better
understand the protective action of E and P, focus was put on fusion and fission processes in astrocytes and
an attempt was made to correlate their regulation with cell viability and apoptosis.
Cultured cortical astrocytes were treated with E concentrations known to be effective in the brain (Luconi
et al., 1999; Ivanova et al., 2002; Pawlak et al., 2005; Rune et al., 2006; von Schassen et al., 2006; Araujo et
al., 2008). Under basal (physiological) conditions, cultured cortical astrocytes from males and females did
not differ in their characteristics for mitochondria morphology and cell viability. E appeared to stimulate
proliferation in females, whereas P facilitates cell death in males. The age-related drop of E levels in females
may, thus, play a role for the vulnerability of cortical neurons in late-onset neurodegenerative disorders,
such as Alzheimer’s disease, due to reduced astrocyte stimulation and survival. We might speculate that the
prevalence for Alzheimer’s disease observed for females is causally linked to decreased E levels and astrocyte
activation. Notwithstanding the importance of our observations, we did not provide a pathological model
with our experimental set-up. For E-treated cortical astrocytes of both genders, a correlation between Mfn1
and anti-apoptotic marker Bcl2 transcription as well as Drp1 and proliferation marker PCNA transcription
was made. This indicates a role of Mfn1 in anti-apoptotic processes and Drp1 in cell proliferation and is in
agreement with the generally accepted role of fusion genes in anti-apoptotic processes and fission genes in
proliferation and apoptosis (Yaffe, 1999; James et al., 2003; Karbowski and Youle, 2003; Olichon et al., 2003;
Yoon et al., 2003; Lee et al., 2004; Stojanovski et al., 2004; Chen and Chan, 2005; Chen et al., 2005; Chan, 2007).
These studies also revealed gender differences in the transcription of Mfn1 and Drp1 showing higher levels in
females which were accompanied by lower apoptotic cell death and elevated number of viable cells. The role
of Drp1 in mitochondrial fragmentation was previously supported by the discoveries that Drp1 mutations
blocked and Drp1 over-expression increased mitochondrial proliferation (Bleazard et al., 1999; Labrousse et
al., 1999). Furthermore, Drp1 was co-localized with constrictions in mitochondria that can coincide with
actual division events (Bleazard et al., 1999; Labrousse et al., 1999). During mitosis, Drp1 is involved in fission
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of mitochondria, a phenomenon that might facilitate the partitioning of fragmented mitochondria to daughter
cells during cytokinesis (Taguchi et al., 2007). This makes Drp1 a factor of controlling mitochondrial division
and a potential candidate for steroid-mediated regulation of cell proliferation, although the involvement of
Drp1 in apoptosis cannot be completely ruled out (Frank et al., 2001). The Drp1/Fis1 ratio was deliberately
chosen to describe proliferative and apoptotic events in astrocyte cultures. This enables the discrimination of
both opposite mechanisms in cultures of equal numbers of viable cells. A constant number of cells does not
allow to conclude whether there is an effect or no effect on both processes by hormones.
Comparing the anti- and pro-apoptotic marker gene transcription with apoptotic cell death, it becomes
evident that an increase or the absence of differences in Bax compared to Bcl2 is related to increased or
unchanged apoptosis level, respectively. The apparent discrepancy between the effect of P on male astrocytes
showing a reduced Bax transcription and increased apoptotic cell death can be clarified by determination
of the Bax/Bcl2 ratio, which is elevated. This points at an increase of apoptotic cell death, although the
individual values of Bax and Bcl2 in males are below the basal levels found in controls.
A clear gender-specific difference in the apoptosis rate of steroid-treated astrocytes was observed and
could be correlated with fusion and fission gene transcription. Female astrocytes showed a mainly balanced
increase of both, fusion and fission gene transcription. This can be considered as a reason for a balanced
transcription of anti- and pro-apoptotic marker genes. On the contrary, fusion and fission gene transcription
in males was imbalanced. Consequently, this imbalance caused a disturbance of the equilibrium between
anti- and pro-apoptotic marker genes, thus promoting apoptotic processes specifically in male astrocytes
treated with gonadal steroids. A higher level of fusion gene transcription supports the increased astrocyte
viability in females (Zuchner et al., 2004; Kijima et al., 2005). This could be partially due to the role of
mitochondrial fusion processes in mixing mitochondrial DNA copies, thereby keeping high loads of mutated
mitochondrial DNA below the threshold of developing diseases (Nakada et al., 2001; Chen and Chan, 2005;
Chan, 2007).
The increased apoptosis in male astrocyte cultures could only be compensated by an elevation of
proliferation resulting in an unchanged level of viable cells after steroid hormone treatment. Indeed, E-
treated male astrocytes exhibited a higher PCNA/Bax ratio than P-treated cells. A ratio of PCNA/Bax >
1 together with an increased proliferation marker transcription at constant levels of apoptosis in female
astrocytes after steroid treatment caused an elevated number of viable cells. In contrast, male astrocytes
demonstrated an increased proliferation after E treatment which compensated for the increased apoptosis,
thereby demonstrating a similar number of viable cells as in untreated controls. However, a decreased
proliferation after P treatment of male astrocytes was not able to counterbalance the increased apoptotic
cell death leading to a net-decrease of viable cells. Other authors have similarly demonstrated E to increase
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glial cell proliferation (Jung Testas et al., 1992; Dhandapani and Brann, 2002), whereas no effect of P on
cell proliferation was described. This could be due to the fact that gender-specific differences observed for
P-treated astrocytes are counterbalanced in cell cultures of mixed genders.
In conclusion, these results show for the first time that sex steroids are capable of influencing fusion
and fission processes in astroglia mitochondria. Importantly, this effect occurred in a gender-specific way
and revealed distinct differences in the effectiveness between E and P. Under physiological conditions, sex
steroids may be important for the balance of mitochondrial morphology and function in the brain. After toxic
events and under neuropathological conditions, sex steroids may differently contribute to the homeostasis
and integrity of cell function, thus providing a basis for the well-known gender differences in neuronal
vulnerability and cell death. These findings suggest a pronounced sensitivity of male astroglia for apoptosis,
which may serve as an explanation for the higher incidences of neurodegenerative diseases in males (Miller
et al., 1998; Roof and Hall, 2000; Dluzen and McDermott, 2004; Kenchappa et al., 2004; Marchetti et al., 2005).
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Abstract
Mitochondria are responsible for major cellular functions including metabolism, signalling and apopto-
sis. Deciding between survival and death, mitochondria play a central role in tissue development and
maintenance as well as in senescence and disease. Recent research has revealed the intimate connection
of mitochondrial physiology to their morphology. The complex and dynamic processes of mitochondrial
fusion and fission regulate the maintenance of the mitochondrial network. When imbalanced, they cause
deep changes in mitochondrial architecture and consequently on their function. Mitochondrial diseases
include many neurodegenerative disorders and mitochondria are perfect targets for neuroprotection. Steroid
hormones, as progesterone and estrogen, influence brain development and neuroprotection directly and
indirectly through their action on the neuroprotective astrocytes. These studies aim at understanding the
effects steroid hormones have on the fission and fusion events in mitochondria and what contribution
this might play in brain development and the involved tissue specializations, influencing neuroprotec-
tion. To investigate how mitochondrial fusion and fission processes might be involved in developmental,
tissue-specialization mechanisms, the fusion Mfn1 and Mfn2, and the fission Drp1 and Fis1 mRNA levels
were measured during mouse brain cortex development. The results correlate very well with the previous
published work by others on the stages of cell growth and specializations during mice cortex development,
and have shown several sex-specific differences.
5.1 Introduction
Mitochondria play a fundamental role in many important cell functions including energy metabolism, thermo
genesis, calcium homeostasis, cell growth, division, signalling and regulation of apoptosis. Their dysfunction
can therefore cause important cellular disequilibrium due to diminished cell energy, production of reactive
oxygen species, disturbance of ionic balance, cytochrome C release and lately apoptosis (James et al., 2003;
Yoon et al., 2003; Lee et al., 2004; Chen et al., 2005). Mitochondrial functions and characteristics explain
their direct connection to aging and various diseases including cancer, obesity, diabetes, cardiovascular
disorders and several neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), autosomal
dominant optic atrophy, Charcot-Marie-Tooth, Parkinson, Huntington’s and Alzheimer’s diseases and
others, stressing the importance of understanding the mechanisms underlying mitochondrial functions
(Chapter 1.4.1) (Alexander et al., 2000; Delettre et al., 2000; Bach et al., 2003; Chen et al., 2004; Zeviani and
Donato, 2004; Zuchner et al., 2004; Chen and Chan, 2005; Kijima et al., 2005; Tatsuta and Langer, 2008)
Mitochondria usually assume a tubular network morphology, but are present in cells in different shapes
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and quantity and also have distinct distributions inside the cell, accumulating in high energy demanding
cellular regions. Several studies suggest that mitochondria do not just differ in their morphology and
distribution inside the cell, but that they are also biochemically and functionally diverse in different tissues
(Benard et al., 2006), and even inside the same cell (Kuznetsov et al., 2006). The mitochondrial morphology
is controlled by two opposing and balanced processes, fusion and fission. These processes of organelle
shaping occur far more times than the necessary to maintain mitochondrial morphology, and are therefore
thought to be essential for the proper functioning of mitochondria. In fact, fission is necessary for the
even distribution of mitochondria to the daughter cells during cell division, and is essential in apoptosis
(James et al., 2003; Yoon et al., 2003; Lee et al., 2004; Stojanovski et al., 2004). Fusion, on the other side,
serves the exchange of carriers and nutrients, and allows for mtDNA molecules exchange and the gene
complementation that prevents the detrimental effects of accumulating mtDNA mutations and cellular
dysfunction (Nakada et al., 2001; Chen and Chan, 2005; Chan, 2007). The fusion and fission processes
controlling mitochondrial morphology, are each regulated by a specific set of proteins. Fusion is dependent
on mitochondrial GTPases mitofusin 1 and 2 (Mfn1, Mfn2), located in the mitochondrial outer wall and
being responsible for the membrane tethering between two mitochondria during fusion, and dominant optic
atrophy-associated protein (OPA1), an intermembrane protein thought to participate in the mitochondrial
inner membrane fusion and cristae modelling. Mitochondrial fission on the other hand, is regulated by
mitochondrial fission 1 protein (Fis1) an outer mitochondrial membrane-bound protein, and dynamin-
related protein 1 (Drp1), a cytoplasmic protein, recruited to the mitochondrial surface during fission. Other
proteins were found to be involved in the processes of mitochondrial remodelling, like Ugo1 and Mdv1
and there is currently active investigation to disclose these mechanisms (Santel et al., 2001; Rojo et al.,
2002; Chen et al., 2003; Olichon et al., 2003; Cipolat et al., 2004; Griparic et al., 2004; Chen and Chan, 2005).
The mitochondrial morphology maintenance is dependent on the equilibrium of these two opposing and
constant processes. An imbalanced expression of fusion or fission proteins disrupts this equilibrium and
causes dramatic changes in mitochondrial morphology leading to dysfunction (Yaffe, 1999; Karbowski and
Youle, 2003). In humans, mutations in Mfn2 cause Charcot-Marie-Tooth neuropathy type 2A (Zuchner et
al., 2004; Kijima et al., 2005) and mutations in OPA1 lead to autosomal dominant optic atrophy (Alexander
et al., 2000; Delettre et al., 2000). The tissue-specificity of some mutations could be connected to a time-
point in development. To understand these diverse tissue-specific phenotypes, it is critical to elucidate the
relative importance of mitochondrial fusion and fission processes in development and in connection to
abnormal cell conditions. A down-regulation of fusion proteins or an over-expression of fission proteins
causes fragmentation of the tubular mitochondrial network. Cells lacking Mfn1 and Mfn2, or OPA1, lacked
mitochondrial fusion and showed severe dysfunctions, such as widespread heterogeneity of mitochondrial
5.1. Introduction 73
membrane potential, decreased cellular respiration, poor cell growth, increased susceptibility to cell death,
and apoptosis (James et al., 2003; Yoon et al., 2003; Lee et al., 2004; Chen et al., 2005). Mfn1 or Mfn2 Knock-out
mice dye during embryogenesis, demonstrating the essential role of mitochondrial fusion in embryonic
development and cell viability (Chen et al., 2003). Small interfering RNA (siRNA) knock-down of OPA1
induced fragmented mitochondria with dissipation of membrane potential and cristae disassembly, which
render highly sensitized cells to exogenous apoptotic stimuli (Olichon et al., 2003; Griparic et al., 2004; Lee
et al., 2004). In C. elegans, over-expression of fission protein Drp1 increased the number of mitochondrial
divisions (Labrousse et al., 1999). Fis1 over-expression caused mitochondrial fragmentation and aggregation
(Stojanovski et al., 2004). It is important to retain that mitochondrial fragmentation does not always result in
apoptosis (Lee et al., 2004). On the other side, over-expression of fusion proteins or down-regulation of fission
proteins stimulates mitochondrial fusion and the development of an elongated mitochondrial network,
inhibiting the apoptosis-related mitochondrial fragmentation and therefore providing protection against
different apoptotic stimuli (Smirnova et al., 2001; Santel et al., 2003; Sugioka et al., 2004). Fis1 knock-down
by small interference RNA blocked the recruitment and activation of Bax to the surface of mitochondria
after a death stimulus indicating an essential role for Fis1 in apoptosis (Lee et al., 2004). Similarly, a loss
of Drp1 blocked mitochondrial fission and cytochrome c release, although it did not significantly interfere
with Bax activation (Breckenridge et al., 2003; Lee et al., 2004). The connection between mitochondrial
fusion and apoptosis inhibition through cell signalling first came from the identification of Mfn2 (called
previously hyperplasia suppressor gene HSG) as an important anti-proliferating protein, which interferes
with the Ras pathway and blocks signalling from growth factor receptors at the plasma membrane (Chen et
al., 2004). Furthermore, the pro-apoptotic protein Bax was found to co-localize with Mfn2 and Drp1 sites
on mitochondria during apoptosis (Karbowski and Youle, 2003) and an activated form of Mfn2 blocked
Bax activation and cytochrome c release, protecting cells from apoptosis (Neuspiel et al., 2005). These
discoveries strongly point towards the importance of the morphological state of mitochondria in relation to
their activity and cellular functions, through the involvement of cellular signalling cascades. Interestingly,
the cell functions managed by mitochondria are also modulated by steroid hormones (Nilson et al., 2002;
Kipp et al., 2006). Although the mechanisms for these are still not fully understood, mitochondria were found
to have interactions with glucocorticoid, estrogen, androgen, and progesterone receptors (Gavrilova-Jordan,
2007). In previous studies, it was observed that estrogen stimulates the expression of mitochondria-encoded
subunits of the respiratory chain, and influences mitochondrial respiratory activity (Araujo et al., 2008),
while others have shown the direct interaction of estrogen with respiratory chain complexes (Zheng and
Ramirez, 1999).
Steroid hormones are known to be important regulatory signals for brain development and in biological
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functions (Hutchison et al., 1997; Beyer, 1999; Mendez et al., 2005; Daniel, 2006; McCarthy, 2008). The
developing and adult brain cells express receptors for progesterone and estrogen (Zhang et al., 2002; Mitra
et al., 2003; Quadros et al., 2007), being therefore unmistakable targets of these hormones, even though
during development, male have a stable PR presence, while female have little. The PR is transcribed by
activated ER, showing the effects caused by these hormones are intimately connected. Estrogen plays an
essential role in late embryonic and early postnatal brain development, controlling cell growth, neurons and
astrocytes morphometry and tissue differentiation, regulating cell apoptotic degeneration, synaptogenesis,
organization of brain circuits and sex-specific differentiation of the CNS (Mesano and Jaffe, 1997; Beyer,
1999; Woo et al., 2001; McCarthy, 2008). Estrogen does not only originate from the foetuses gonads and
the feto-placenta-maternal unit (Tuchinsky et al., 1972; Trotter et al., 1999), but is also synthesized locally
in the nervous tissues. The aromatase subcellular localization next to synaptic terminals shows a possible
E action like a neurotransmitter. Estrogen receptors were also found in the axon and dendrites terminals,
seemingly too far to return to the nucleus for transcription activation, suggesting a nontranscriptional effect
of ER in the nervous system or, most probably, a local interaction with neighbouring mitochondria which
locate next to synapses (McCarthy, 2008). The neuroprotective effects of estrogen and progesterone have
been described by several research groups. Astrocytes play an essential role in the support and protection of
neurons, being therefore able to influence neuroprotective processes in the brain (Beyer, 1999; Beyer et al.,
2003; Garcia-Segura et al., 2003; Kajta and Beyer 2003; Kipp et al., 2006). Astroglial cells express estrogen and
progesterone receptors, being therefore known targets of these steroid hormones (Jung-Testas et al., 1992).
There are some studies on the effects of estrogen and progesterone and their interaction with mitochondria,
but the connection of these steroid hormones to the mitochondrial fusion and fission processes is still
not elucidated. Knowing mitochondria play an important part in tissue differentiation, this small project
aimed at clarifying the relative proportion of mitochondrial fission and fusion, apoptosis and proliferation
mechanisms during the development of the mouse cortex. These studies aim at the understanding of
the effects estrogen and progesterone might have on the fission and fusion events in mitochondria, thus
influencing their morphology and function, and what contribution this might have during mouse brain
cortex development and astrocyte survival, influencing later neuroprotection.
5.2 Materials and Methods
For information on the materials and methods used in this study, please refer to Chapter 2.
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5.3 Results
5.3.1 Ontogenic regulation of mitochondrial fusion and fission gene
transcription
To verify the connection of mitochondrial fusion and fission processes to the development of cortical brain
cells, the transcription of fusion (Mfn1, Mfn2) and fission genes (Drp1, Fis1) was analysed along with
markers of proliferation (PCNA) and apoptosis (Bax and Bcl2) in mouse brain cortices on late embryonic
development days E15 and E17 and early postnatal days P0 (birth), P7, and P15. Therefore, cortex tissue was
isolated from mice in the several developmental stages, total RNA was extracted and used to produce cDNA
for PCR analysis. Semi-quantitative RT-PCR (sqRT-PCR) was performed for the genes of interest (for details
please refer to Chapter 2, section 2.7) and PCR results were normalized against the respective housekeeping
genes, 18S rRNA and HPRT, results. The significance of differences between the groups of different ages
was determined according to a T-test by comparing samples of different ages with the youngest group
E15. During development, Mfn1 transcription was mostly leveled in the first 3 stages of development, then
lowering considerably in P7 when female and male cortex showed a significant decrease of the transcription
of Mfn1 from E15 to P7 by approximately two-fold (Fig. 5.1 A, D). In females, the lowest level of Mfn1
transcription on P7 then greatly and significantly increased on P15, almost reaching the transcription levels
in E15 (Fig. 5.1 A). In males, Mfn1 expression did not significantly change from P7 to P15 (Fig. 5.1 D). The
Mfn2 transcription levels were quite different to the Mfn1 levels, showing no significant changes in females
during the development stages studied, while in males, Mfn2 expression significantly increased from P7 to
P15 by approximately a third (Fig. 5.1 D). To these changes in the transcription profile of each of the fusion
genes studied, should be added the significant differences in the levels of Mfn1 versus Mfn2 transcription at
the same development stage. Thus, in females, the level of Mfn1 in P7 is less than half of the level of Mfn2,
the same holding true for males in both P7 and P15. Mfn2 levels being about the double transcription level
to Mfn1, showing a significant mitofusin 2 transcription preference (Fig. 5.1 D). There was also a sex-related
significant difference in Mfn1 versus Mfn2 levels in P15 in males in contrast to females (Fig. 5.1 A, D). The
transcription of fission genes did not show any significant changes until P15, when Drp1 was significantly
augmented in female cortical brain tissue, but not in male brain cortex, denoting another sex-specific effect
(Fig. 5.1 A, D; Fig. 5.2 B). Fis1 transcriptions were not significantly altered during brain cortical development
over the time period studied (each stage in comparison to E15), even though Fis1 shows an increasing
tendency with the developmental age in female brain cortex but not in male (Fig. 5.1 B, E). Transcription of
the proliferation marker, PCNA, along with the pro- and anti-apoptotic marker, Bax and Bcl2, were gradually
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and significantly down-regulated in female cortical tissue from E15 to P15 (Fig. 5.1 C). In male cortical
tissue, PCNA also reduced gradually and significantly during development, while Bcl2 transcription was
not significantly changed and there was only a significant reduction of Bax in P15 (Fig. 5.1 F). At embryonic
ages, proliferation, anti-, and pro-apoptotic marker levels were higher in female than in male cortices, but
aligned in the post-natal days. These results show very obvious sex-differences in the transcription levels of
the genes studied. The levels of Fis1 and Drp1 in female and male show a significant difference in P15 (Fig.
5.2 A, B). Further significant sex-differences are shown on Bcl2 and Bax gene transcription (Fig 5.2 C, D), on
E15 and E17, further also on P0 for Bcl2 only (Fig 5.2 C). At those developmental stages, female have higher
transcription values of Fis1, Drp1, Bcl2 and Bax.
5.4 Discussion
In mouse development, cortex forms at embryonic day 14 (E14), when migrating cells from telencephalon
compose the superficial cortical area of the primary cortex, which is then easily recognized at E15, enlarging
considerably in the following days. The brain continues developing and differentiation of accessory struc-
tures further takes place until two weeks after birth (Theiler, 1989). Estrogen blood concentrations during
mouse development include a gradual increase from day E13 until a maximum level is reached at E17, dimin-
ishing to the lowest estrogen levels on P0 and increasing during the first week after birth (Beyer, 1999). On
the other side, Aromatase P450, the enzyme responsible for the transformation of testosterone in estrogen, is
expressed in neurons of the developing and adult brain (Schumacher et al., 2003; Prange-Kiel et al., 2006; Von
Schassen et al., 2006). Estrogen can also be synthesized de novo from cholesterol and the necessary enzymes
are also present in the female and male developing brain. Because of local synthesis, steroid hormones can
reach much higher local concentrations than anticipated and the greater aromatase activity in males than in
females might be responsible for the sex brain dimorphism (Hutchison et al., 1997; Beyer, 1999; Quadros et al.,
2007). Thus, the local brain synthesis of estrogen seems to compensate for the lower estrogen concentration
from the blood stream during the late embryonic and early post-natal days. This time interval is believed to
be the estrogen’s sensitivity-window which allows for major permanent brain modifications, including brain
sex differences connected to adult sexual behavior (McCarthy, 2008). Although it is well known that estrogen
increases cell proliferation (Jung-Testas et al., 1998), how it would influence mitochondrial fusion and fission
remained unanswered. The results presented here confirm the high pre-natal cellular proliferation rates
through a high transcription of the proliferation marker PCNA and mitochondrial fusion and fission proteins,
needed for the proper distribution of mitochondria to daughter cells and morphology maintenance. The
pro- and anti-apoptotic markers Bax and Bcl2 are also highly expressed, probably for the simultaneous
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Figure 5.1: Transcription of mitochondrial fusion and fission proteins, apoptosis and proliferation markers
in the developing cortex of female and male mice. Brain cortices from female (A, B, C) and male Balb/c mice
(D, E, F) of embryonic day 15 and 17 (E15 and E17, respectively), and postnatal days 0, 7, and 15 (P0,
P7, and P15, respectively) were isolated. Total RNA was extracted and first strand cDNA was synthesized
for amplification of Mfn1, Mfn2, Fis1, Drp1, Bcl2, Bax, and PCNA by sqRT-PCR. Data were normalized
to housekeeping genes 18S rRNA and HPRT and represent means ± SEM of three to five independent
experiments. Statistically significant differences between groups as compared to the E15 (* - P<0.05, ** -
P<0.01, *** - P<0.001) and between other groups as connected by a line (# - P<0.05, ## - P<0.01, ### -
P<0.001) were determined using Student’s unpaired t-test.
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Figure 5.2: Sex differences on the transcription of mitochondrial fission proteins (Fis1 and Drp1), apoptosis
(Bax) and anti-apoptotic (Bcl2) markers in the developing brain cortex of female (lighter columns) and
male mice (darker columns) at the time in development when the differences became significant. Brain
cortices from female and male Balb/c mice of embryonic day 15 and 17 (E15 and E17, respectively), and
postnatal days 0, 7, and 15 (P0, P7, and P15, respectively) were isolated. Total RNA was extracted and first
strand cDNA was synthesized for amplification of the genes of interest by sqRT-PCR. Data were normalized
to housekeeping genes 18S rRNA and HPRT and represent means ± SEM of three to five independent
experiments. Statistically significant differences (#- P<0.05, ## - P<0.01, ### - P<0.001) between groups
were determined using Student’s unpaired t-test.
apoptotic and survival mechanisms connected to tissue differentiation. In the two weeks after birth, brain
cell proliferation is lower, cell differentiation is intensified and accompanied by a rise in the number of
mitochondria in cell somata (Gregson & Williams, 1969; Samson et al., 1960). Accordingly in the results
described here, after birth there is a significant decrease of transcription of the proliferation marker PCNA
and a much higher transcription of the anti-apoptotic marker Bcl2 compared to the pro-apoptotic marker
Bax, resulting in cell survival. Simultaneously, Mfn1 transcription was decreased and Drp1 transcription
increased, although in female only, on P7 and P15, respectively (Fig. 5.1 A, B, D), indicating enhanced
mitochondrial fission in a sex-dependent fashion. These observations support reports on a rapid increase of
mitochondrial division and volume between P7 and P15, which then rise gradually until adulthood (Pysh,
1970; Erecinska et al., 2004). An increased proliferation is mostly physiologically advantageous for a cell
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population during development or undergoing cell death. Under maintenance conditions however, the
expression of fusion proteins and pro-apoptotic proteins is induced to counteract mitochondrial fission and
cell proliferation, thereby keeping the cell number on a constant level and preventing cells from deterioration
into cancer cells. The latter is an unwanted side-effect of estrogen therapy for postmenopausal women
developing breast cancer (for review, see Yager and Davidson, 2006). Higher mitochondrial fission in female
cortical astrocytes could result on either apoptosis or elevated cell growth in female cortex (Lee et al., 2004;
Breckenridge et al., 2003). It is well known that brain sex differentiation involves apoptosis. The more
extensive mitochondrial division in female could possibly lead to apoptosis in some areas of the brain,
maybe even regarding tissue specializations leading to sexual differences in the brain cortical tissue. In the
preoptic area, the sexually dimorphic nucleus of male mice, responsible for male-sex-behaviour, is five to
seven times larger than in the females, due to estrogen directed apoptosis in female, between P3 and P7.
Through the same estrogen regulated apoptosis mechanism, but in reversed sex, so is the anteroventral
periventricular nucleus bigger in females than in males (McCarthy, 2008). Several studies have shown
that sex-related differences are also evident in the human cortex tissue, as for example in the Broca’s and
Wernicke’s areas related to language-associated thoughts, which were significantly larger in women. Using
magnetic resonance imaging, the scientists measured the volumes of gray matter in several cortical regions
and reached the conclusion that women had 23% (in Broca’s area, in the dorsolateral prefrontal cortex) and
13% (in Wernicke’s area, in the superior temporal cortex) more volume than men (Schlaepfer et al., 1995).
Another research presented morphological evidence that men have more neurons in the cerebral cortex,
while women have a more developed neuropil, the space between cell bodies, which contains synapses,
dendrites and axons, and is responsible for communication between neurons. According to the scientists,
this may be the reason why women are more prone to dementia (for example Alzheimer’s disease) than
men, as although both could possibly lose the same amount of neurons due to the disease, the functional
reserve may be greater in males, as a larger number of nerve cells are present, and this could prevent some
functional losses (Rabinowicz et al., 1999). How these mechanisms are triggered and occur in a sex- and
brain region -specific way is still to be clarified. In physiological conditions, cellular effects are induced by a
net-effect of several substances and pathways, in the interconnected systems belonging to an organism. The
tissue-specificity of some mutations could be connected to a time-point in development. To understand these
diverse tissue-specific phenotypes, it is critical to elucidate the relative importance of mitochondrial fusion
and fission processes in development and in connection to abnormal cell conditions. Further research on
the single phenomena occurring in the physiological conditions needs to be done as to continue unraveling
these processes.
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Chapter 6
General discussion
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Due to the increasing world’s older population, dementing diseases could soon become main causes
of disability, what demands for active research in neurodegeneration protection, generally named neuro-
protection. Astrocytes play an important role in neuroprotection, for they support neuronal metabolism,
neurotransmitter synthesis and energy homeostasis of the brain (Behl, 2002; Dhandapani and Brann, 2007;
Pellerin et al., 2007; Schousboe et al., 2007), pointing at mitochondria in astrocytes as a most probable
compartment involved in neuroprotection. Mitochondria are key players in many essential cell functions,
including energy metabolism, thermogenesis, intracellular calcium homeostasis, cell growth, division, sig-
nalling and also apoptosis (Bettini and Maggi, 1992; Behl, 2002; Chen et al., 2004). Because mitochondria
not only are key players in essential cell functions, but also function as integrators of diverse cellular stress
and toxic signals (Greenamyre et al., 1999; Reynolds, 1999; Choo et al., 2003; Beal, 2005), their dysfunction
may therefore cause major cellular imbalance. Interestingly, the cell functions managed by mitochondria
are also modulated by steroid hormones (Nilson et al., 2002; Kipp et al., 2006). Herewith, it is known that
for a wide range of neurodegenerative diseases, there is a sex-specific incidence and course (Gillies et al.,
2004; Poole et al., 2008; Schapira, 2008; Schulman, 2007), most probably connected to the sex-specific brain
differences described (Hutchison et al., 1997; Beyer, 1999; Quadros et al., 2007, McCarthy, 2008). This adds to
the brain-region specificity of several diseases and clearly indicates that further research comparing brain
regions and sex differences as well as brain development and aging, is essential for the therapy research.
With this in mind, some studies presented here were performed in isolated female and male astrocyte
cultures, as well as on the developing cortex tissue of female and male mice. The processes by which steroid
hormones are related to, and possibly regulate, mitochondria, need to be clarified further and are subject of
current research.
In this study, chapter 3 is dedicated to the steroid hormone effects on mitochondrial respiration and it is
shown there that E affects mitochondria in a time and concentration dependent manner. E promotes the
expression of selected representative mitochondrial-encoded subunits of the respiratory chain in different
proportions and up to 100% more than in control conditions, influencing mitochondrial respiratory activity
and enhancing functional efficiency (Chapter 3). Studies by others support these results (Zheng and Ramirez,
1999; Chen et al., 2004; Irwin et al., 2008). These effects were also brain-region-specific, being much higher in
the mesencephalic cells than on the cortical cells, as is the case for cytB and ATP6 expression. Why some
genes were transcribed more than others and what consequences this might have, needs to be clarified
further, but it is here hypothesized that this might be related to the sensitivity of the different respiratory
complexes to malfunction, the most sensitive ones being the most transcribed genes as to substitute the
malfunctioning proteins in a protective mechanism.According to the results described in chapter 3, the most
sensitive respiratory complexes, being the ones which genes are transcribed most, would be Complex IV and
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V (Cox2 and ATP6) in brain cortex and Complex III and V (CytB and ATP6) in mesencephalon. Why these
proteins would be more sensitive as hypothesized here, remains to be elucidated. It is also target of further
research what other effects in the cell E provokes and their relation to this subunit transcription augmentation.
The co-treatment of cells with estrogen and the nuclear estrogen’s receptor antagonist ICI, did not influence
the results obtained with estrogen’s treatment alone, showing that the stimulation of mitochondrial gene
expression is independent of the nuclear ER, the classical pathway, and is rather due to direct E effects on
mitochondria. Others have demonstrated the localisation of ERα and ERβ to mitochondria and related
their presence to the mediation of functional effects caused by E treatment (Monje et al., 2001; Mitra et al.,
2003; Chen et al., 2004; Yager and Chen, 2007; Milner et al., 2008). Furthermore, the ratio of mitochondrial
to nuclear DNA, was increased in both cortical and mesencephalic astrocyte cultures, but much higher in
mesencephalic cultures as on the cortical, here also, agreeing with the previous results of higher respiratory
chain gene expression (Araujo et al., 2008). The elevated mtDNA levels and the increased transcript levels
of mtDNA-encoded subunits of the respiratory chain, indicate an elevation of the mitochondrial mass
in the cells, as under the study conditions, there were no changes in the astrocyte proliferation levels
under E treatment as compared to controls. To understand what effect the estrogen’s stimulated higher
expression of respiratory chain genes, and the amount of mitochondrial to nuclear DNA, might have on the
actual respiratory activity of the cells, mitochondria were isolated and polarographic measurements of their
oxygen consumption stimulated by the addition of the substrate succinate were made. Interestingly, cortical
astrocytes had up to two-fold higher activity of isolated mitochondria than mesencephalic. Unexpectedly,
after a long-term treatment (8 and 12h) of E there were no significant differences in the respiration of E-treated
versus untreated cortical and mesencephalic astrocytes stimulated by succinate, ADP or CCCP, nor on the
efficiency of energy production, RCR. This discrepancy was thoroughly discussed in chapter 3, and the
values presented were supported by the work of others according to the conditions and substrate used.
Nevertheless, mitochondrial respiration coupling is dependent on the membrane conditions of the isolated
mitochondria, and another attempt was made to evaluate the intactness of the isolated mitochondria, using
scanning electron microscopy, SEM (many thanks to D. Alves). The pictures show well kept membranes,
inclusively very clear inner membrane invaginations (Fig. 3.6), which show that a fair degree of intactness of
the mitochondria is kept and which are supported by the proposed 3D model of mitochondrial imaging of
Manella (Manella, 2000). Isolated mitochondria have been described since decades as small and spherical
to elliptical. During the extraction, which obliges to the breakage of cells and necessarily, breakage of the
mitochondrial net, the method cannot preserve mitochondria in their original physiological structure. Even
though isolated mitochondria do not compare to mitochondria in physiological conditions, the form showed
here is similar to one of the isolated mitochondria forms depicted by others, as being smaller, elliptical
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mitochondria with randomly disposed cristae appearing to be floating free in the inner compartment (Ambu
et al., 2000).
Besides the studies on the respiration of mitochondria after a long-term treatment of E, a short time
treatment was also tested, as to see what immediate effects E might have on mitochondrial respiration. A
short time treatment with E (5 min) led to a brain-region specific decrease of the succinate-stimulated oxygen
consumption of cortical mitochondria, and a tendency to increase that of the mesencephalic respiration,
although not significantly. Interestingly, RCR values remained unchanged for mitochondria from astrocytes
of both brain regions, indicating that short-term E treatment of astrocytes does not influence the efficiency
of mitochondrial energy production, and only affects the activity of proton-translocating complexes of the
respiratory chain. Without compensation in form of up-regulation of ATP synthase units or ATP synthase
activity, this effect could lead to the hyperpolarisation of the mitochondrial membrane and the higher
production of deleterious reactive oxygen species (ROS). This indicates that short-term E treatment is less
effective for improvement of mitochondrial function and survival of astrocytes in the mesencephalon, while
E protects cortical astrocytes by decreasing respiration to a level where there is lower ROS production.
This might in fact be a mechanism of cell protection. Furthermore, the differences in the expression of the
respiratory chain genes and respiratory activities in the different brain regions might be related to, and
even explain, the different sensitivity of brain regions to ischemic processes and degeneration, and also to
therapies.
Another point of interest in studying mitochondrial function is the relation of physiology to morphology,
or vice-versa. The mitochondrial net architecture seems to dictate the optimal functioning and cellular
distribution of mitochondria according to the cells energetic and physiological demands. Several studies
suggest that mitochondria differ not only in their morphology and cellular location but also that they are
biochemically and functionally diverse in different tissues (Benard et al., 2006) and also inside the same cell
(Kuznetsov et al., 2006). The mitochondrial net architecture is controlled by fusion and fission processes and
the mitochondrial form re-adaptations occur far more often than the necessary to maintain mitochondrial
morphology, pointing at their physiological processes as the reason for such mechanisms. Additionally, a
higher fusion to fission ratio results in some protection against apoptosis, while a higher fission could lead to
apoptosis, but is also necessary during cell division for the equal distribution of mitochondria to the daughter
cells (Taguchi et al., 2007; Stojanovski et al., 2004; Sugioka et al., 2004). In chapter 4 of this work, the effects
of steroid hormones on the mitochondrial fusion and fission gene transcription in astrocytes are addressed.
It is shown there that steroid hormones influence the mitochondrial fusion and fission gene transcription
of cultured astrocytes from cortex and mesencehalon, of female and male mice. For cortical astrocytes of
both genders, a correlation between Mfn1 (fusion) and anti-apoptotic marker Bcl2 transcription as well as
86 Chapter 6. General discussion
Drp1 (fission) and proliferation marker PCNA transcription was made, as supported by the results from
others, showing the role of fusion genes in anti-apoptotic processes and fission genes in proliferation and
apoptosis (Yaffe, 1999; James et al., 2003; Karbowski and Youle, 2003; Olichon et al., 2003; Yoon et al., 2003;
Lee et al., 2004; Stojanovski et al., 2004; Chen and Chan, 2005; Chen et al., 2005; Chan, 2007). The studies
presented here also revealed gender differences in the transcription of Mfn1 and Drp1 showing higher
levels in females which were accompanied by lower apoptotic cell death and elevated number of viable
cells. Treatment of female cortical astrocytes with E or P 10−7 M for 24 h induced a pronounced increase by
approximately 50% in the number of viable cells, while in male cells, the application of E did not shown any
effect, whereas P decreased the number of viable cells. A clear gender-specific difference in the apoptosis rate
of steroid-treated astrocytes was observed and could be correlated with fusion and fission gene transcription.
While female astrocytes showed a mainly balanced increase of both fusion and fission gene transcription
and probably therefore also a balanced transcription of anti- and pro-apoptotic marker genes, in males the
fusion and fission gene transcription was imbalanced, which seems to have caused a disturbance of the
balance between anti- and pro-apoptotic marker genes, thus promoting apoptotic processes specifically
in male astrocytes treated with gonadal steroids. A higher level of fusion gene transcription supports the
increased astrocyte viability in females (Zuchner et al., 2004; Kijima et al., 2005), while it is very possible that
the increased apoptosis in male astrocyte cultures could be compensated by an elevation of proliferation,
which would result in an unchanged level of viable cells after steroid hormone treatment, as compared
to untreated controls. In fact, male astrocytes treated with E exhibited a higher PCNA/Bax ratio than
P-treated cells. Female astrocytes, on the other hand, showed a ratio of PCNA/Bax > 1 and the resulting
proliferation increase at constant levels of apoptosis elevated the number of viable cells. In male astrocytes,
however, a decreased proliferation after P treatment was not able to counterbalance the increased apoptotic
cell death leading to a decrease of viable cells. Other authors have similarly demonstrated E to increase
glial cell proliferation (Jung Testas et al., 1992; Dhandapani and Brann, 2002), whereas no effect of P on
cell proliferation was described. This could be due to the fact that gender-specific differences observed
for P-treated astrocytes are counterbalanced in cell cultures of mixed genders. The transcription levels of
pro-, anti-apoptotic and proliferation markers (Bax, Bcl2, and PCNA, respectively), correlated very well
to the viability results. Interestingly, the PR inhibitor usually blocked P’s effects partially to totally, while
ER inhibitor did not affect E’s effects. It is noteworthy that E influences mitochondria not only through its
nuclear receptors, but acts also directly by binding of E to mitochondria in vitro and in situ (Yang et al., 2004;
Stirone et al., 2005; Yager and Chen, 2007; Milner et al., 2008). Thus, some effects, in particular those exerted
by E but not by P, were not subject to inhibition by classical nuclear ER antagonists.
The brain development is another very interesting field to research upon, aiming at understanding the
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characteristics of mitochondria during development, the essential tissue specializations and the possible
relation to steroid hormones. The results presented in Chapter 5 of this thesis are supported by the
described stages of brain development in the time window researched. It is shown here that there is
a high pre-natal cellular proliferation rate through a high transcription of the proliferation marker PCNA and
mitochondrial fusion and fission proteins. These would be needed for the proper distribution of mitochondria
to daughter cells and morphology maintenance. The pro- and anti-apoptotic markers Bax and Bcl2 are also
highly expressed, probably for the simultaneous apoptotic and survival mechanisms connected to tissue
differentiation. After birth there is a significant decrease of transcription of the proliferation marker PCNA
and a much higher transcription of the anti-apoptotic marker Bcl2 compared to the pro-apoptotic marker
Bax, which might be resulting in cell survival. This is in accordance with studies by others, in which, in the
two weeks after birth, brain cell proliferation is reduced, cell differentiation is intensified and accompanied
by a rise in the number of mitochondria in cell somata (Gregson & Williams, 1969; Samson et al., 1960).
Simultaneously, Mfn1 transcription was decreased and Fis1 and Drp1 transcription increased, although
in female only, on P7 and P15, respectively indicating enhanced mitochondrial fission in a sex-dependent
fashion for Drp1. These observations are supported by reports on a rapid increase of mitochondrial division
and volume between P7 and P15, which then rise gradually until adulthood (Pysh, 1970; Erecinska et al.,
2004). In physiological conditions, cellular effects are induced by a net-effect of several substances and
pathways. E is known to induce P receptor transcription (McCarthy, 2008), therefore sensitizing cells to
progesterone action. There are most probably other processes involved in the physiological conditions, and
further research is being done currently.
Generally, this work presents a small contribution to the clarification of the effects of steroid hormones on
mitochondrial properties of astrocytes, more specifically in the respiratory physiology and in the morphologic
characteristics of astrocytic mitochondria. Future research will clarify these mechanisms further, in order to
possibly explain region and sex-specific sensitivity differences in the brain, connected to the incidence and
course of neurodegenerative diseases and help shed light into possible mechanisms of neuroprotection.
To understand the mechanisms by which steroid hormones act on the mitochondrial morphology and
physiology, and how the respiration and the fusion and fission mitochondrial balance is affected, further
research on apoptosis challenged cell cultures could be pursued. As techniques improve, imaging would
also surely provide exciting pictures of the mitochondrial changes during different cell status and under
steroid hormone treatments. Further knowledge on the mitochondrial characteristics is surely going to play
a meaningful role in future disease therapies.
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Summary of the Thesis
Several points of interest in the neuroprotection field are approached in this work: steroid hormones,
astrocytes and mitochondria. Steroid hormones, such as estrogen and progesterone, are well-known to
regulate cell growth, function and protection in the central nervous system (CNS). Astrocytes play a major
role in the brain’s energy metabolism, growth, regulation of cerebral blood flow, coupling neuronal activity
and regulation of synapses, as well as neuroprotection. Furthermore, the essential cellular energy metabolism,
regulation of cell growth, division, signaling and also of apoptosis, is dependent on the mitochondrial
functions. This explains why mitochondrial dysfunction can cause important cellular imbalance and is
connected to aging and disease, including many neurodegenerative infirmities. Interestingly, the cell
functions managed by mitochondria are also modulated by steroid hormones, so that it seems mitochondria
are perfect targets for strategies of cellular protection. In the first part of this thesis, focus is put on the
energy metabolism regulation in the CNS. Steroid hormones are well-known to fulfill a protective role in
the brain during ischemic and degenerative processes. Mitochondrial dysfunctions due to abnormalities of
the mitochondrial respiratory chain often accompany neurodegenerative diseases, in which, degeneration
often shows brain region specificity. Since astrocytes function as the major energy supplier in the CNS,
the estrogen effects on the mitochondrial respiratory chain were here analyzed in primary astrocytes
from the brain regions cortex and mesencephalon. It was observed that estrogen influences subunit gene
expression of respiratory chain complexes, the mitochondrial DNA content and the functional respiration
of isolated mitochondria differently, according to the estrogen exposure time as well as depending on the
brain region. This could be related to the different sensitivity of brain regions to degeneration and also point
at an important indirect mechanism by which estrogen protects neurons from cell death under neurotoxic
conditions. On a subsequent chapter, the processes of mitochondrial fusion and fission that regulate energy
metabolism, apoptosis, and cell proliferation, were approached. In this respect, astrocyte mitochondria seem
to be a perfect intracellular target for steroids to modulate these processes. Therefore, the effects of estrogen
and progesterone on cell viability in comparison with mitochondrial fusion and fission gene transcription in
primary cortical astrocytes from female and male mouse brains are studied here. Estrogen- and progesterone-
treated astrocytes demonstrated differences in cell number and proliferation marker accompanied by a
corresponding difference of fusion and fission gene transcription, in a gender-dependent way. It seems
estrogen and progesterone affect mitochondrial function differently in both genders. Therefore, interaction of
sex steroids with mitochondria may represent one possible cause for gender differences in cellular pathology
in the CNS. The last part of this thesis focuses on mitochondrial fusion and fission processes during mouse
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brain development. Mitochondria are responsible for major cellular functions, therefore playing a central
role in tissue development and maintenance as well as in senescence and disease. The complex and dynamic
processes of mitochondrial fusion and fission regulate the maintenance of the mitochondrial network. When
imbalanced, they cause deep changes in mitochondrial architecture and consequently on their function.
Steroid hormones, as progesterone and estrogen, influence brain development and neuroprotection directly
and indirectly through their action on the neuroprotective astrocytes. These studies aim at understanding
the effects steroid hormones have on the fission and fusion events in mitochondria and what contribution
this might play in brain development, tissue-specialization mechanisms and astrocyte survival, influencing
neuroprotection. Therefore , the mRNA levels of the target fusion and fission genes were measured during
mouse brain cortex development. The results correlate very well with the previous published work by
others, on the stages of cell growth and specializations during mice cortex development, and have shown
some sex-specific differences.
Zusammenfassung der Dissertation
Mehrere Schwerpunkte aus dem Bereich Neuroprotektion werden in dieser Arbeit behandelt: Steroid-
hormone, Astrozyten und Mitochondrien. Steroidhormone wie O¨strogen und Progesteron regulieren das
Zellwachstum, die Funktion und den Schutz im zentralen Nervensystem (ZNS). Astrozyten spielen eine
wichtige Rolle bei solchen Prozessen und auch beim Energiestoffwechsel des Gehirns. Daru¨ber hinaus sind
der wesentliche zellula¨re Energiestoffwechsel, die Regulation von Zellwachstum, Zellteilung, Signaling
und auch die Apoptose von der Mitochondrienfunktion abha¨ngig. Dies erkla¨rt, warum mitochondriale
Dysfunktion ein nennenswertes zellula¨res Ungleichgewicht verursachen kann und mit Alterung sowie vielen
neurodegenerativen Erkrankungen in Verbindung steht. Interessanterweise werden die Zellfunktionen, die
von Mitochondrien gewa¨hrleistet werden, auch durch Steroidhormone moduliert, so dass die Mitochondrien
als perfekte Ziele fu¨r Strategien zum Zellschutz erscheinen.
Im ersten Teil dieser Arbeit liegt der Schwerpunkt auf der Regulation des Energiestoffwechsels im ZNS.
Steroidhormone spielen im Gehirn eine schu¨tzende Rolle bei ischa¨mischen und degenerativen Prozessen.
Mitochondriale Funktionssto¨rungen aufgrund von Vera¨nderungen der mitochondrialen Atmungskette be-
gleiten oftmals neurodegenerativen Erkrankungen, bei denen die Degeneration oft Gehirnregion-spezifisch
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ist. Da Astrozyten als der wichtigste Energieversorger im ZNS fungieren, wurde in dieser Arbeit die
O¨strogen-Wirkung auf die mitochondriale Atmungskette in prima¨ren Astrozyten von Kortex und Mesen-
cephalon untersucht. Es zeigte sich, dass O¨strogen die Genexpression der Atmungskettenkomplexe, den
mitochondrialen DNA-Gehalt,die Menge an Mitochondrien pro Zelle, und dadurch, die funktionelle At-
mung in isolierten Mitochondrien, unterschiedlich in Abhngigkeit von der O¨strogen-Expositionszeit und der
Gehirnregion gea¨ndert hat. Dies ko¨nnte mit der unterschiedlichen Sensitivitt verschiedener Hirnregionen
gegenber Degenerationsprozessen verbunden sein, und auch auf einen wichtigen indirekten Mechanismus
hindeuten, u¨ber den eine O¨strogen-Exposition Neuronen vor dem Zelltod unter neurotoxischen Bedingun-
gen schu¨tzt.
In einem spa¨teren Kapitel wird die mitochondrialen Fusions- und Spaltungsprozesse, die Energiestof-
fwechsel, sowie Apoptose und Zellteilung regeln, untersucht. Diesbezglich stellen Astrozyten-Mitochondrien
einen perfekten intrazellula¨ren Angriffspunkt fu¨r Steroide zur Modulierung dieser Prozesse dar. Deshalb
werden hier die Einflsse von O¨strogen und Progesteron auf die Lebensfa¨higkeit der Zellen im Vergleich
mit der Gentranskription der mitochondrialen Fusion und Spaltung in prima¨ren kortikalen Astrozyten
weiblicher und ma¨nnlicher Ma¨use-Gehirne untersucht. O¨strogen- und Progesteron-behandelte Astrozyten
zeigten geschlechtsabhngig A¨nderungen in ihrer Anzahl sowie hinsichtlich der Proliferationsmarker, be-
gleitet von einer mit Fusion und Spaltung verbundenen Gen-Transkription. Es scheint, dass O¨strogen und
Progesteron die Mitochondrien-Funktion bei beiden Geschlechtern unterschiedlich beeinflussen. Somit
ko¨nnen die Wirkungen von Sexualhormonen auf Mitochondrien eine mo¨gliche Ursache fu¨r geschlechtsspez-
ifische Unterschiede in der Zellpathologie des ZNS darstellen.
Der letzte Teil dieser Arbeit konzentriert sich auf die mitochondrialen Fusions- und Spaltungs-Prozesse
wa¨hrend der Gehirnentwicklung der Maus. Mitochondrien sind fu¨r wichtige Zellfunktionen verantwortlich
und spielen daher eine zentrale Rolle bei der Gewebentwicklung und dessen Erhalt sowie beim Altern und
bei Erkrankung. Die komplexen und dynamischen Abla¨ufe bei der Mitochondrien-Fusion und Spaltung
regeln die Aufrechterhaltung des mitochondrialen Netzwerks. Wenn sie unausgewogen sind, provozieren
sie tiefgreifende Vera¨nderungen in der mitochondrialen Architektur und damit in ihrer Funktion. Steroid-
hormone wie Progesteron und O¨strogen beeinflussen die Entwicklung des Gehirns und die Neuroprotektion
direkt und indirekt ber ihre Wirkung auf die neuroprotektiven Astrozyten. Die vorliegenden Untersuchun-
gen zielen darauf ab, die Auswirkungen, die Steroidhormone auf die Spaltungs- und Fusions-Vorga¨nge
der Mitochondrien haben, zu verstehen und zu erkla¨ren, welchen Beitrag dies bei der Gewebeentwicklung
und -differenzierung und beim U¨berleben der Astrozyten und damit bei der Beeinflussung der Neuro-
protektion liefern ko¨nnte. Dazu ist der mRNA-Spiegel von Fusions- und Spaltungs Genen wa¨hrend der
Hirnrindenentwicklung der Maus gemessen worden. Die Ergebnisse korrelieren in Bezug auf die Phasen von
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Zellwachstum und -differenzierung wa¨hrend der Entwicklung der Ma¨use-Hirnrinde sehr gut mit den bereits
vero¨ffentlichten Arbeiten anderer Gruppen und haben auerdem einige geschlechtsspezifische Unterschiede
gezeigt.
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18S rRNA 18S ribosomal RNA;
ADP adenosine diphosphate;
ATP adenosine triphosphate;
ATP6 ATP synthase (complex V), subunit 6;
a.u. arbitrary units;
Bax Bcl2-associated X protein;
Bcl2 cell lymphoma protein 2;
BSA bovine serum albumine
CCCP carbonyl cyanide m-chlorophenylhydrazone;
cDNA first strand complementary DNA;
CNS central nervous system;
COX cytochrome c oxidase;
Cox2 cytochrome c oxidase (respiratory complex IV), subunit 2;
CytB ubiquinol cytochrome c oxidoreductase (complex III), subunit cytochrome b;
Ct threshold cycle;
DEPC diethyl pyrocarbonate;
DMEM Dulbecco’s modified Eagle medium;
Dnm1l dynamin 1 like protein, synonym of Drp1;
Drp1 dynamin-related protein 1;
E estrogen (general term);
E2 17β-estradiol;
E15/17 embryonic day 15 or 17;
EDTA ethylenediamine-tetraacetic acid
ER estrogen receptor;
FCS fetal calf serum;
Fis1 fission 1 homolog (mitochondrial outer membrane);
GFAP glial fibrillary acidic protein;
H, H2O2 hydrogen peroxide;
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid;
HPRT hypoxanthine guanine phosphoribosyl transferase;
ICI ICI182,780, estrogen nuclear receptor inhibitor;
IMM inner mitochondrial membrane;
Mfn1 mitofusin 1;
Mfn2 mitofusin 2;
mtDNA mitochondrial DNA;
NBM neurobasal medium;
ncDNA nuclear DNA;
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NADH nicotinamide adenine dinucleotide, reduced form
ND1 NADH ubiquinone oxidoreductase (complex I), subunit 1;
OD optical density;
OMM outer mitochondrial membrane;
Opa1 optic atrophy associated protein 1;
OSCP oligomycin-sensitivity conferring protein;
P progesterone;
P0/7/15 post-natal day 0 (birth), 7 or 15;
PCNA proliferating cell nuclear antigen;
PR progesterone receptor;
qRT-PCR quantitative real time-PCR;
RCR Respiratory Control Ratio;
ROS reactive oxygen species;
RTI, RTI3021-022 progesterone receptor inhibitor;
S staurosporine;
siRNA small interfering RNA;
sqRT-PCR semi-quantitative, reverse transcriptase-PCR;
TN Turnover Number.
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